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Abstract 
Background: Acute exercise is becoming an increasingly popular approach for treating anxiety 
symptoms in individuals with clinical and/or subclinical levels of anxiety. However, there has 
been limited empirical effort in studying such anxiolytic effects in individuals of this specific 
target population (i.e., those with elevated anxiety). This has consequently led to floor effects in 
the literature. There further has been inadequate focus on women, who are significantly more 
affected by these symptoms. Finally, yoga has not been adequately studied for such effects, 
although it has become a mainstream alternative health practice approach by many individuals.  
Objectives: The purpose of this study was to examine the efficacy of a single bout of vinyasa-
style yoga versus a stretching control condition for improving immediate and delayed cognitive 
and physical anxiety symptoms induced by a 5-minute, 7.5.% CO2-inhalation protocol in women 
with self-reported high anxiety sensitivity.  
Methods: In a within-subjects design, 18 women with elevated anxiety sensitivity completed 1 
baseline session, and 2 experimental conditions in a randomized, counterbalanced order. Yoga 
and control conditions consisted of 40 minutes of guided vinyasa-style yoga and light stretching, 
respectively. Participants completed the 7.5% CO2-inhalation task before, immediately after and 
1 hour after the experimental conditions and filled out questionnaires on state anxiety, panic and 
anger before and after the inhalation. Respiratory measures (i.e., respiration rate, ventilation, 
tidal volume, CO2 production) and self-reported overall anxiety data were collected via a 
metabolic cart attached to the mouthpiece during the inhalation task. Repeated measures 
ANOVAs were conducted for all outcome measures.  
Results: Based on the results of the 3-way ANOVA, there was no evidence for a differential 
pattern of change in self-reported or respiratory outcomes in response to the inhalation task 
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between the 2 conditions (p>.05). There was a significant main effect of inhalation (i.e., from 
pre- to post-inhalation) on the self-reported panic and anxiety symptoms in both conditions 
(p<.05). Finally, collapsed over exposure and condition, there was a slight reduction in cognitive 
anxiety over time (i.e., from baseline to immediately post and 1-hour post-inhalation task). 
Conclusion: A light-to-moderate intensity vinyasa-style yoga does not appear to be more 
efficacious than a light stretching session for improving symptoms of anxiety and panic in 
response to the anxiogenic 5-minute, 7.5% CO2-air mixture inhalation task. However, there 
appears to be an overall effect of general physical activity for attenuating cognitions of anxiety, 
irrespective of the physiological responses. Furthermore, the inhalation task administered in the 
present study appears to be a reliable method for mimicking both acute panic and more 
generalized anxiety state symptoms under laboratory conditions.  
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CHAPTER 1: INTRODUCTION 
 Anxiety disorders (ADs) are among the most prevalent forms of mental illness, affecting 
approximately 26% of the US population (Kessler et al., 2005) and costing approximately $43 
annually (National Institute of Mental Health; NIMH, 2001).Women are twice as likely as men 
to be diagnosed with or suffer from clinical and subclinical levels of anxiety, and yet they are 
only half as likely to receive treatment for it. Furthermore, even though currently used behavioral 
and drug therapies can be effective (Hofmann & Smits, 2008; Mitte et al., 2005), only 15% of 
those diagnosed receive the even minimally adequate treatment they need (Mohr et al., 2010; 
Wang et al., 2002; 2005) due to a variety of reasons (e.g., high cost, lack of access, stigma). In 
fact, epidemiological studies indicate that ADs are often not recognized and that the doctors tend 
to overlook anxiety (Ormel et al., 1990).  The lack of recognition was reported to be an even 
bigger problem for those with less severe symptoms related to their AD (Ormel et al., 1990). 
This is concerning, as ADs significantly increase the risk for other conditions such as depressive 
disorder, heart disease and diabetes (Shearer, 2007), and has been reported to be just as disabling 
as other disorders, such as major depressive disorder (Wittchen et al., 2000). These collectively 
underscore the necessity to find more accessible, alternative ways to effectively address 
symptoms of clinical and subclinical anxiety. 
 Exercise has been suggested as one such alternative method to help alleviate symptoms 
of anxiety. A recent meta-analysis (Ensari et al., 2015) of 36 randomized controlled trials (RCTs) 
on the anxiolytic effect of acute exercise concluded that there was a small but statistically 
significant (Hedge’s g=0.16) beneficial effect of exercise. The moderator analyses indicated that 
exercise of high intensity and using the treadmill in particular, yielded larger effects (p<0.05). 
However, the authors concluded that the findings from this meta-analysis should be interpreted 
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with caution due to 2 major limitations of the literature; (1) Participants in these studies often did 
not have high baseline anxiety levels or a clinical anxiety disorder, resulting in floor effects and 
thus disabling researchers to determine the true effect of exercise on anxiety-reduction; and (2) 
the exercise stimulus (e.g., intensity, duration, type) was often not described in sufficient detail 
or lacked clear rationale. Accordingly, such acute exercise studies can help more accurately 
determine exactly what kind of exercise stimuli is best for reducing symptoms of anxiety in 
prone individuals. Once these effects are determined via acute bouts of exercise, such findings 
can then inform the design of chronic/longitudinal exercise interventions to compare their 
efficacy to other forms of therapy (i.e., behavioral and drug therapy). Accordingly, these 
limitations need to be addressed in well-designed studies, given the already existing evidence 
that exercise can be beneficial for anxiolysis. 
 Yoga as an exercise modality has been getting more common in the western parts of the 
world as an alternative treatment approach for a variety of negative health symptoms (e.g., pain, 
fatigue, mood) (National Center for Complementary and Alternative Medicine, NCCAM; 2007). 
Yoga practice involves physical postures that mimic stretching, balance and strength exercises. 
Depending on the style of the yoga, there can also be substantial focus on the breathing, 
deliberate attention on linking breath to movement and meditation within the practice. This is an 
important component of yoga as it pertains to anxiolysis. That is, some studies have reported that 
individuals suffering from anxiety disorders may misconstrue experiences that others may judge 
as normal response in such a way as to elicit intense feelings of panic and fear, i.e., increased 
anxiety sensitivity (AS) (Taylor, 1996; Taylor et al., 1991; Sandin et al., 2001). Accordingly, a 
regular practice of yoga involving greater focus on breathing and connecting it to movement may 
produce improvements in mood and anxiety symptoms by reducing the tendency to react to 
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negative mental and physical states with ruminative thought or maladaptive behavior)(i.e., 
desensitization). Furthermore, a possibly additive anxiolytic benefit of a faster-paced (e.g., 
moderate intensity) style of yoga (i.e., vinyasa) has not been investigated by previous research. 
Given the previous meta-analytic evidence on the efficacy of high intensity exercise for 
anxiolysis (Ensari et al., 2015), it is important to delineate such effects to determine if this style 
of yoga is a better method for alleviating anxiety symptoms in individuals who are prone to 
problematic anxiety levels. 
 One such approach to studying the anxiolytic effects of acute exercise is by using a well-
established, validated paradigm of anxiety (and panic) induction, such as the CO2-inhalation 
challenge (Bailey et al., 2007). The use of the CO2-inhalation protocol allows countering the 
potential floor effects commonly observed in the previous studies (Ensari et al., 2015). This 
method has been validated to reliably induce panic and more general anxiety symptoms in both 
healthy and clinical populations (Bailey and Nutt, 2008). However, only 5 studies on exercise 
have been published to date that use the CO2-inhalation paradigm as an anxiety induction method 
to study anxiolysis (i.e., Esquivel et al., 2002, 2008, 2012; Smits et al., 2009; Broman-Fulks et 
al., 2015). Furthermore, these studies have all utilized a 35% CO2 single, vital-capacity 
inhalation procedure to induce/mimic symptoms of panic disorder in their participants. However, 
no studies thus far have used a longer (e.g., ~5 minutes) CO2-inhalation protocol to mimic 
symptoms of Generalized Anxiety Disorder (GAD) in a similar setup. Accordingly, findings 
from these studies limit our ability to assess the true anxiolytic effects of exercise, as the 
anxiogenic effect of this stimulus might not be an accurate representation of most real life 
anxiety inducing situations (i.e., those that last longer than a few seconds) and other types of 
anxiety disorders (e.g., GAD). Indeed, it is possible that the longer duration is a better 
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representation of real life anxiety situations and therefore the response to an exercise stimulus 
might be more relevant. This needs to be addressed in subsequent investigations of the anxiolytic 
effect of acute exercise. 
 The proposed study further enrolled a sample of only women. Two reasons provided the 
basis for recruiting a sample consisting only of women: first, women are significantly more 
likely to suffer from a clinical GAD diagnosis and/or subclinical symptoms of anxiety and 
second, anxiogenic responses to the CO2-inhalation protocol can vary between men and women, 
with women exhibiting greater anxiety symptoms. Some studies have indicated that this might be 
due to hormonal reasons (Ben-Zion et al., 1999; Perna et al., 2005). Controlling for this potential 
confounder can aid in the determination of a more isolated effect of exercise in response to the 
CO2-inhalation challenge. Accordingly, the proposed study attempted to control for the phase of 
the menstrual cycle phase (i.e., luteal vs. non-luteal). 
Aims and Hypotheses 
 The proposed study aimed to fill in the gaps in the current literature regarding acute 
exercise and anxiety symptoms by investigating the immediate and delayed anxiolytic effects of 
a single session of guided vinyasa-style yoga in response to 5 minutes of anxiogenic CO2-
inhalation protocol in a sample of women with high AS. A sample with a score of 25 or higher 
(i.e., 0.75 SD > published population norms) on the ASI were targeted based on the previous 
reports that this is a robust, consistent predictor of anxiogenic response to the CO2-inhalation 
task (Smits et al., 2009). 
Accordingly, the present study had several hypotheses: 
Primary hypotheses: 
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1) Yoga would significantly attenuate the anxiogenic responses to the CO2-inhalation in 
comparison to the control condition. This hypothesis was partially based on the greater emphasis 
on the breathing meditation component inherent in yoga, which might make the participants 
more cognizant of their breathing and therefore respond differently to the CO2-inhalation after 
this condition. In addition, it might be due to the greater cognitive engagement required while 
doing yoga than engaging in other exercise modalities (e.g., walking/running), activities and 
sitting quietly (e.g., during the control condition). 
Secondary hypotheses: 
1) Yoga condition would lead to slightly greater decreases in the post-CO2 inhalation self-
reported anger scores response in comparison to the control condition. This change effect would 
be greater in those with greater baseline depressive and anxiety symptom levels. This is based on 
the previous findings that anger has been consistently reported to co-occur in individuals with 
anxiety and depressive symptoms (Fava et al., 1998; Gould et al., 1996). 
2) An acute improvement in the respiratory profile would accompany the self-reported 
improvements proposed in primary results. Specifically, respiratory rate (RR) and ventilation 
(VE) were expected to show an attenuation while tidal volume (Vt) was expected to increase, 
from before to immediately- and 1 hour-post-condition during the CO2-inhalation tasks in the 
yoga condition. This was based on previously reported findings from individuals with sensitivity 
to this type of CO2-inhalation protocols (i.e., Schaeffer, 1958). These collectively could point to 
an acute, improved respiratory response profile (i.e., respiratory efficiency) as a result of the 
yoga intervention (vs the stretching control condition) in this sample of individuals with high AS 
(i.e., “high-responders”).  
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This study can help determine the true effects of a bout of yoga, an exercise modality that 
is becoming exceedingly popular but has not been studied as extensively as others, under more 
ecologically valid conditions (i.e., biologically induced anxiety and in individuals with high AS). 
These results can subsequently inform the design of effective, targeted yoga and exercise 
interventions for individuals with clinical and subclinical symptoms of mood disturbance.  
Furthermore, the assessment of the physiological response can help determine whether 
behavioral and physiological responses to the inhalation task parallel each other or whether there 
are incongruences in individuals with AS. For example, no significant change in physiological 
response but significant improvement (i.e., reduction) in self-reported anxiety and panic 
symptoms might indicate cognitive adaptation to hyperventilation in this population. 
Accordingly, these results would collectively further underscore the feasibility of using yoga to 
target anxiety and panic problems. Ultimately, such findings can provide patients with anxiety 
disorders and health care professional working with such patients with guidelines for effectively 
using yoga as an exercise modality to effectively target their symptoms. 
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CHAPTER 2: LITERATURE REVIEW 
 The proposed randomized controlled study evaluated the efficacy of a single bout of 
guided vinyasa-style yoga for improving anxiety and related mood symptoms (e.g., anger) in a 
sample of women with self-reported AS. The subsequent sections review the following: 
prevalence of anxiety disorders (ADs) and generalized anxiety disorders (GADs) in the general 
population and comparisons between men and women, risk factors, antecedents and 
consequences associated with GADs, current treatment modalities and exercise as an alternative 
approach for treating anxiety symptoms, yoga as an exercise modality and alternative approach 
for treating anxiety symptoms, CO2 inhalation protocol as a biological anxiety model, and the 
association between exercise-induced anxiolysis in response to CO2-inhalation challenges. 
Finally, possible mechanisms through which CO2 might be mimicking symptoms of generalized 
anxiety and how yoga might be countering this effect are also addressed. 
Anxiety Disorders and Generalized Anxiety Disorder 
 Anxiety disorders (ADs) affect approximately ¼ of the US population (Kessler et al., 
2005). Epidemiological studies have reported that they have the highest overall prevalence rate 
among psychiatric disorders, with a 12-month rate of 18.1% and a lifetime rate of 28.8% 
(Kessler et al., 2005; Kessler et al., 2005a; Ramos et al., 2003). GAD is the most frequently 
presented class of ADs in primary care (i.e., ~22% of patients with anxiety complaints). 
According to the Fifth Edition of the Diagnostic and Statistical Manual (DSM-V) (American 
Psychiatric Association, 2013) and the Tenth Edition of the International Classification of 
Diseases (ICD-10) (World Health Organization, 1992), GAD is characterized by excessive and 
inappropriate worrying that is persistent (lasting some months in ICD-10, six months or longer in 
DSM-V) and not restricted to particular circumstances. Patients with GAD have physical and 
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psychological symptoms (restlessness, fatigue, difficulty concentrating, irritability, muscle 
tension and disturbed sleep). GAD can be comorbid with major depression (but not arise solely 
in its context), panic disorder, phobic anxiety disorders and OCD in DSM-V, but must not meet 
full criteria for these in ICD-10.  
 GAD has an estimated prevalence of 8% in the general population and a remission rate of 
less than 20% within a 5-10 year period (Ballenger et al., 2001). Furthermore, the prevalence 
rates for GADs have remained consistent over time, in comparison to other psychiatric disorders, 
such as phobias and depressive disorders (Wittchen, 2002). Other studies have suggested that 
when compared with chronic medical disorders, there is evidence that GAD is just as equally 
disabling (Kessler, 2005a). Finally, given that the typical onset occurs in early adulthood based 
on a median diagnosis age of 26.6 (McLean et al, 2011), ADs clearly result in significant 
reduction in quality of life for all those diagnosed. Evidently, all of these aspects of the disease 
collectively affect various domains of functioning in individuals, including quality of life 
(Kroenke et al., 2007), cardiovascular health and social life (Wittchen et al., 2000). It further is a 
nation-wide problem, with significant job productivity/work impairment (Ludman et al., 2006; 
Sareen et al., 2005) and cost more than 43$ billion annually in the US alone (NIMH, 2001). 
 There is a large body of evidence that ADs, and especially GAD, pose a significantly 
larger problem for women than for men. For example, women are twice more likely than men to 
be diagnosed with an AD in adulthood (Pigott, 2003; Vesga-Lopez et al., 2008). Some authors 
have reported lifetime and 12-month prevalence rates of any AD as 1.7 and 1.79 times greater in 
women than in men (McLean et al., 2011). Furthermore, women with a lifetime AD diagnosis 
are more likely to also be diagnosed with another AD or depressive disorder (Saunders et al., 
2012; McLean et al., 2011); and a greater illness burden is associated with AD in women than in 
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men, suggesting that ADs are more disabling in women than in men. These collectively 
underscore the importance of addressing this public health issue by targeting women for 
adequate and proper treatment of ADs. 
 Traditional treatment methods of pharmacotherapy (e.g., anxiolytics, antidepressants) and 
behavioral therapy (e.g., cognitive behavioral therapy (CBT)) have been indicated as moderately 
effective in treating ADs (Mitte, 2005; Mitte et al., 2005; Hofmann & Smits, 2008). Review of 
the literature suggests that these 2 modalities appear to be comparable in their efficacy for 
treating GAD, based on moderate effect sizes of d=0.60 and d=0.70 for pharmacotherapy and 
CBT, respectively (Gould et al., 1997). However, there are limitations to these approaches, in 
particular with regards to response, relapse and side effects. For example, 14–43% of the patients 
have been reported not to respond to treatment and 18–48% to relapse within 6 months (Barlow 
et al., 2000; Foa et al., 2005). In addition, these therapeutic approaches are associated with a 
range of unpleasant side-effects and limitations (e.g. high financial costs, inaccessibility, 
inconsistent response rates, and high relapse rates after discontinuation). For example, one study 
reported that scores on measures of quality of life (QOL) for these patients remained lower than 
those of the normal population even after successful treatment (e.g., Safren et al., 1997). This is a 
concern as low QOL may also represent a risk factor for relapse after successful treatment 
among anxiety disorder patients (Olatunji et al., 2007). A review published on the efficacy of 
pharmacotherapy concluded that there is still an important, unmet need for a fast-acting 
anxiolytic agent lacking unwanted side-effects of classical, full agonist, non-selective 
benzodiazepines (BZ) (Whiting, 2006). Furthermore, it has been reported that less than 15% of 
individuals with an AD diagnosis receive minimally adequate treatment (Mohr et al., 2010; 
Wang et al., 2005). Other studies have reported that not only men are more likely than women to 
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have access to and use medical services, women are significantly less likely to receive necessary 
medical services from health care professionals when compared to men (Wang et al., 2002; 
2005). Collectively, these underscore the importance of identifying alternative symptom 
management methods to target symptoms of anxiety both in clinical and non-clinical 
populations, and in particular, for women.   
Risk factors and antecedents of Generalized Anxiety Disorder  
 Several genetic/biological (e.g., impaired serotonergic neurotransmission, dysregulated 
corticotropin-releasing factor; CRF) and environmental (e.g., early life experiences, trauma) 
factors have been indicated in subsequent development of GAD in life. In general, it is thought 
that a genetic disposition coupled with early stress in critical phases of development may result 
in a phenotype that is neurobiologically vulnerable to stress and may lower an individual’s 
threshold for developing clinical and subclinical levels of anxiety symptomology upon further 
stress exposure (Allgulander, 2010; Behar et al., 2009; Heim & Nemeroff, 1999). Therefore, the 
manifestation of clinical and subclinical anxiety symptomology can be thought of the confluence 
of dynamic, reciprocal interactions between genetic vulnerability and environmental stressors. 
 While the possibility of a genetic basis for GAD has been studied by several cohort 
studies and meta-analyses (e.g., Hettema et al., 2001; Torgersen, 1983), the results appear to be 
mixed. For example, one meta-analysis indicated 31.6% variance explained by familial 
aggregation (mostly due to genetic heredity) based on a best-fitting model to predict GAD 
(Hettema et al., 2001). The same model further predicted common familial environment only in 
women, and the rest of the variance due to non-shared environmental factors. Yet others have 
reported lower rates (i.e., 14.3% variance) when the GAD definition is more restrictive (Roy et 
al., 1995). Similarly, a large cohort twin study of monozygotic and dizygotic twins indicated that 
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the evidence for hereditary genetic factors in the development of GAD do not appear to be as 
strong as other risk factors (i.e., environmental and developmental) (Torgersen, 1983). Finally, 
studies using molecular genetic mapping methods to identify GAD-relevant loci have reported 
serotonin to be an important neurotransmitter. For example, one study reported that functional 
variations in the promoter of the serotonin transporter gene (the 5HTTLPR polymorphism) is 
associated with enhanced amygdala reactivity to the processing of emotional stimuli (Hariri et 
al., 2002), which is an important characteristic feature of GAD. Similarly, others reported that 
reduced expression of the 5HTTLPR was associated with increased limbic reactivity to 
emotional stimuli (Dannlowski et al., 2007). These findings collectively provide evidence for a 
genetic disposition to developing GAD, which might then exacerbate the impact of 
environmental risk factors.  
 Environmental factors, and in particular those leading to early childhood stress/trauma, 
have been indicated to have a strong influence on the physiological and cognitive manifestations 
of GAD later in life (Klein, 1980). The cardiorespiratory fitness (CRF) dysregulation theory is 
one of the most commonly accepted mechanisms to explain the mediation of this 
biopsychological pathway. First, early life stress and/or adverse experiences can result in 
persistent central CRF, which is the central coordinator of the endocrinological, autonomic, 
immunological and behavioral stress response. CRF neurons originate from the amygdala and 
project to the locus coeruleus of the Pons, which is involved with physiological responses to 
stress and panic. Specifically, CRF produces many responses that mimic acute stress, including 
increase in HR, mean arterial pressure and catecholamines, disrupted sleep-wake cycles, and 
increased locomotor activity (Heim & Nemeroff, 1999). These are all symptoms often 
experiences by those with an AD. For example, according to a birth cohort study (Moffit et al., 
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2010), patients with a pure GAD diagnosis significantly differed from healthy controls on certain 
risk factors at baseline, including; maternal internalizing symptoms, low socioeconomic status, 
maltreatment, childhood internalizing symptoms, and conduct problems. These respondents also 
had higher scores on inhibited temperament and greater negative affect. Similarly, other studies 
have reported childhood trauma and insecure attachment as significant correlates of subsequent 
development GAD (Borkovec et al., 2004). The insecure attachment (Bowlby, 1982) theory of 
GAD suggests that these individuals might grow up to perceive the world as a dangerous place, 
and lack adequate resources to cope with uncertain events (Cassidy et al., 2009). These findings 
should be interpreted with caution; however, as they lack temporal sequence and therefore 
require further empirical evidence for making conclusive statements.  
 In conclusion, it is evident that these risk factors are in constant interaction with each 
other in the etiology of GAD. Anxiety behavior is an expression of adaptive brain systems that 
are related to survival, and therefore the genes influencing these behaviors most likely act by 
increasing the sensitivity of neural circuits of harm avoidance and threat detection (Smoller et al., 
2008). It is possible that this starting point leads to the aforementioned changes in the CRF 
and/or neurotransmitter systems in the CNS. These persistent, dynamic changes possible then 
interact with the environmental factors to manifest a full clinical GAD. Collectively, these 
findings have important implications for use of exercise training for targeting these symptoms, 
based on the neurobiological and cognitive pathways through which exercise has been indicated 
to induce changes in the CNS (e.g., Petruzzello et al., 1991). That is, studies have been indicating 
for decades that both acute and chronic physical activity can influence the factors discussed 
above. This underscores the importance of carrying out studies that investigate the underlying 
mechanism of the anxiolytic effect of exercise in prone individuals. 
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Physical Activity and Anxiety Disorders 
 Strong associations between the physical activity habits and anxiety symptoms, as well as 
the suggestion of physical exercise as an alternative avenue for addressing these symptoms have 
been reported in the literature (DeBoer et al., 2012; Jayakody et al., 2014). Accordingly, 
investigating patterns of physical activity in individuals with clinical and subclinical levels of 
anxiety is necessary so as to determine how they can be helped to increase their physical activity 
(PA) levels. However, there has been limited research that focuses on the PA and sedentary 
behavior patterns in individuals with pure GADs or even ADs. Instead, most data come from 
heterogenous clinical populations (i.e., samples of individuals with various different psychiatric 
symptoms and diagnoses). From these available data, there is evidence based on both self-
reported and objectively quantified data that individuals with clinical and subclinical levels of 
anxiety are more sedentary than their non-anxious counterparts (Chapman et al., 2015; de Wit et 
al., 2011; Helgadottir et al., 2015). For example, in one cross-sectional study, researchers studied 
the PA behavior of 142 participants who reported symptoms of anxiety and/or mental disorders 
(e.g., depression). All participants filled out PA questionnaires on time spent walking for 
transport, walking for recreation, and moderate-to-vigorous PA (MVPA), and sedentary behavior 
(e.g., TV watching, work, computer use). Participants also wore an accelerometer for 7 days. 
Estimates of time spent in sedentary behavior, light activity and MVPA were calculated in bout 
durations. Results indicated that approximately 70% of participants reported activity levels that 
met the PA guidelines; however, only a small proportion of activity was accumulated in bouts of 
10 minutes or more (Chapman et al., 2015). Furthermore, the questionnaires indicated that the 
participants were highly sedentary. Specifically, participants spent on average, two-thirds of their 
waking time sedentary, and a third of that was accumulated in prolonged bouts. Finally, the 
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authors reported that self-reported PA poorly correlated with accelerometer-based PA data. In 
another similar study conducted with individuals with depressive and/or anxiety disorders, 
authors characterized PA and sedentary behavior in a sample of 165 adults who were in 
outpatient treatment (Helgadottir et al., 2015). All participants scored their mental health 
symptoms using the Montgomery-Åsberg Depression Rating Scale (MADRS) and were 
interviewed using the Mini International Neuropsychiatric Interview (MINI) to assess their 
anxiety and depressive symptoms. Participants also wore an accelerometer for 7 days for 
objective quantification of their habitual PA levels. Results indicated that; 1) only one-fifth of 
the sample followed public health guidelines for PA, 2) each point increase in the MADRS was 
associated with a 2.4 minute reduction in light PA, independent of MVPA and sedentary time, 
and finally 3) MADRS was positively associated with the number of sedentary bouts 
(Helgadottir et al., 2015). The authors noted that there weren’t any significant differences in PA 
or SB patterns between depressed and anxious individuals; and these findings are in accordance 
which those of Chapman et al. (2015). Finally, the authors reported that these individuals spent 
considerably more time in SB compared to the general population. Lastly, another 
epidemiological study demonstrated that after controlling for PA level and sociodemographic 
factors, severity of symptom was positively associated with sedentary behavior involving 
computer and TV consumption (de Wit et al., 2011). Interestingly, the authors of this study 
reported that individuals with ADs spent more time watching TV, compared to those with 
depressive or co-morbid depressive/anxiety disorder. Taken together, these findings are highly 
relevant to public health and health care practitioners. First, there is a need for conducting further 
epidemiological research to objectively quantify these patterns of behavior in individuals with 
pure GADs and ADs in general. Second, they demonstrate that there is a large potential for 
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treatment for individuals with ADs who present with a range of symptoms related to their disease 
by monitoring and manipulating their PA and SB levels. 
Exercise and Anxiety Disorders 
 An increasing body of research indicates that chronic/regular leisure-time physical 
activity (i.e., exercise training) that is correctly targeted and prescribed may be an effective form 
of intervention for individuals with clinical and subclinical symptoms of anxiety (Asmudsen et 
al., 2013; Herring et al., 2007). For example, one meta-analysis reported an effect size of 0.94 for 
the anxiolytic effect of exercise training when compared to no-exercise control conditions, based 
on data collected from samples (N=11) with high trait anxiety (Stich, 1998). The same meta-
analysis reported that this value increases to 0.99 when only those with a formal diagnosis AD 
(N=7) are included in the analysis (Stich, 1998). This magnitude of change should be interpreted 
with caution, however, due to the small number of studies included in the analysis. Based on the 
available data, certain characteristics of the exercise training and anxiety assessment have been 
suggested for maximal effects, including; exercise-training interventions of shorter than 12 
weeks in duration, using training sessions of at least 30 minutes and using a time reference 
longer than the previous week to assess anxiety symptomology (Herring et al., 2007). These 
findings support those from a previous meta-analysis that focused on samples with high trait 
anxiety (Petruzzello et al., 1991). Collectively, these findings provide important information for 
guiding the design of future interventions targeted toward individuals with GAD and in 
particular, women with GAD. 
 There is some evidence suggesting that exercise can be as effective as other traditional 
forms of treatment, such as CBT and drug therapy (Broocks et al., 1998; Fremont and Craighead, 
1987; McEntee & Halgin, 1999). However, studies comparing exercise training to 
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pharmacotherapy and psychotherapy for their anxiolytic effects are significantly limited in 
number in comparison to those that investigate their antidepressant effects for individuals with 
depression. Therefore, there is a critical need for such comparative assessment in samples with 
ADs (and subsequently GADs), given the aforementioned limitations of drug and behavioral 
therapy (i.e., accessibility, relapse likelihood, side-effects) and the benefits of exercise. That is, 
exercise is accessible to everyone, it does not require a medical professional (beyond getting a 
medical clearance for starting exercise for those with possible risks for physical activity (PA) 
participation), and it does not bear financial costs. Furthermore, exercise is associated with 
positive side effects (e.g., improvements in multiple components of fitness, immune and heart 
health) and these aspects collectively make exercise an even more exciting potential treatment 
approach for ADs and a generally desirable everyday tool for all individuals for managing 
anxiety symptoms. This underscores the importance of conducting well-designed, high-quality 
randomized controlled trials (RCTs) to examine such comparative effects and subsequently 
determine the true effect of exercise on clinical and subclinical anxiety symptoms to help inform 
exercise intervention designs and clinical practice. 
Acute Exercise and Anxiety 
 To design high-quality longitudinal studies (i.e., RCTs) that use the correct exercise 
stimulus (i.e., exercise prescription) in their exercise training intervention, it is beneficial to first 
investigate the immediate effects of exercise on anxiety symptoms. To that end, meta-analytic 
evidence indicates an anxiolytic effect of just a single bout of (i.e., “acute”) exercise for 
individuals with high anxiety levels based on effect sizes of 0.24 (Petruzzello et al., 1991) and 
0.16 (Ensari et al., 2015). Specifically, studies of acute exercise interventions indicate that using 
a quiet rest control condition, high exercise intensity, the treadmill as a modality, the 10-item 
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STAI for state anxiety assessment; with female, sedentary and diseased samples yielded larger 
effects for acute exercise. These meta-analyses and systematic reviews collectively agree on the 
under-sampling of participants with high baseline anxiety symptoms to counter possible floor 
effects, improper prescription of exercise treatment and lack of appropriate no-exercise control 
condition. Furthermore, some authors (e.g., Ensari et al., 2015) concluded that these results need 
to be cross-validated in subsequent studies and that even though the results are insightful, they 
should be interpreted with caution considering the small sample of studies included within some 
of the categories in the analysis (e.g., too few exercise modalities beyond cycle ergometer and 
treadmill walking, too few samples with high baseline anxiety levels). These collectively 
underscore the need for further investigation of alternative exercise modalities that have not been 
as extensively investigated for samples with increased proneness to symptoms of anxiety (i.e., 
individuals with clinical or subclinical anxiety symptoms) to understand the true anxiolytic effect 
of acute exercise stimuli. 
 One aspect of exercise that needs to be determined for anxiolysis is the intensity of the 
exercise stimulus. Some meta-analytic findings indicate the moderate intensity might be most 
effective for anxiety relief (Petruzzello et al., 1991); however, more recent meta-analytic 
evidence indicates that higher intensity might be more effective (Ensari et al., 2015). Some 
studies suggest that both low and high intensity exercise can be beneficial for reducing AS; 
however, the specific domains of anxiety and its associated symptoms (e.g., physiological vs 
psychological vs cognitive symptoms) might respond differently to different intensities. For 
example, Broman-Fulks et al. (2004) investigated the anxiolytic effects of light and high 
intensity treadmill walking on AS in 54 participants with elevated AS. All participants completed 
six 20-min treadmill exercise sessions at either a high-intensity aerobic (N=29) or low-intensity 
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(N=25) level. Self-ratings on AS, fear of physiological sensations associated with anxiety, and 
general anxiety were obtained at pre-treatment, post-treatment, and one-week follow-up. Results 
indicated that both high- and low-intensity exercise reduced AS (Broman-Fulks et al., 2015). 
However, high-intensity exercise caused more rapid reductions in the overall measure of AS and 
produced more treatment responders than low-intensity exercise. Furthermore, only high-
intensity exercise reduced fear of anxiety-related bodily sensations. These findings suggest that 
there is potential merit in the further investigation of higher exercise intensities for better 
determination of such immediate effects.  
 Another aspect that warrants further investigation is the determination of the modalities 
of exercise that are most efficacious for anxiolysis. Systematic and meta-analytic reviews agree 
that there is generally a disproportionate focus on cycle ergometer followed by treadmill walking 
as the modality of exercise for investigation of its anxiolytic effects (Ensari et al., 2015; 
Petruzzello et al., 1991). This consequently makes it difficult for researchers to make 
comparisons between studies based on unbiased effect sizes. In addition, some of these less 
studied modalities have been indicated to be more popular among responders (e.g., walking, 
running, yoga) or to have other important health benefits (e.g., increased strength). It is therefore 
important to further investigate these lesser studied alternative modalities as it would allow us to 
determine if some of these modalities are as effective as or more so than the already more 
thoroughly-investigated modalities (e.g., cycling) for anxiolysis. For example, one such modality 
worth exploring is yoga and accordingly, yoga-based exercises.  
Yoga as an Exercise Modality 
 The most widely cited and accepted definition of yoga is as an ancient discipline 
designed to bring balance and health to the physical, mental, emotional and spiritual dimensions 
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of the individual (Iyengar, 1976). Yoga is often depicted as a tree and has 8 components: 
Universal ethics, individual ethics, physical postures (i.e., “asanas”), breath control, sense 
control, concentration and bliss. Despite this multi-faceted nature of yoga, most people usually 
think of the physical aspects, followed by the concentration (i.e., meditation) aspect (Ross and 
Thomas, 2010).  
 Yoga has long been a popular practice in its birth place of India; however, it has gained 
considerable popularity in the western world in the recent years for its wide range of self-
reported benefits; such as fatigue, pain, sleep and mood in healthy and ill populations (Oken et 
al., 2004; Oken et al., 2006; Ross & Thomas, 2010; Yurtkuran et al., 2007). According to a 
survey conducted in 2007 by the National Center for Complementary and Alternative Medicine 
(NCCAM), yoga is the 6th most commonly used complementary health practice among adults in 
the US (NCCIH, 2015). Despite this self-reported acknowledgment of the wide range of benefits 
of yoga; there is currently a small body of research focusing on the possible anxiolytic effects of 
yoga, and in particular, vinyasa yoga.  
For example, Coeytaux et al. (2014) acknowledged that there are considerably more 
studies investigating benefits of yoga for conditions such as depressive symptoms and chronic 
back pain, in comparison to its potential anxiolytic effects. The authors conducted a 
comprehensive evidence-mapping meta-review, and concluded that there is inconclusive 
evidence for the anxiolytic effects of yoga based on the lack of sufficient good-quality studies 
(Coeytaux et al., 2014). Specifically, the authors noted that RCTs that address yoga interventions 
for GAD or panic disorder (PD) were lacking in the published literature. The two systematic 
reviews the authors were able to identify (da Silva et al., 2009; Cabral, 2011) were rated poor 
quality based on methodology (e.g., lack of proper diagnostic criteria for diagnosis of GAD or 
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PD, control group, randomization). The authors concluded that the limited evidence provided 
from non-randomized, lower-quality studies indicates a possible anxiolytic effect for exercise 
and therefore they can serve as a foundation for higher-quality RCTs addressing this question. 
These collectively point to the need to conduct high-quality RCTs to delineate the true anxiolytic 
effect of yoga. Similarly, a qualitative review (Ross & Thomas, 2010) comparing the health 
benefits of yoga to other forms of exercise reported that overall, yoga was just as or more 
effective than exercise for improving a variety of symptoms including heart rate variability 
(HRV), cholesterol, fatigue, negative affect, stress and sleep disturbance. It should be noted that 
although this review does not include any data on anxiety symptoms specifically, it does provide 
some rationale for further investigation of yoga for anxiolysis for the purposes of the current 
study. This is based on the literature indicating strong associations between some of the reported 
symptoms (e.g., HRV, negative affect, stress, sleep disturbance) and anxiety symptomology 
(e.g., Carney et al., 2003; Hughes et al., 2010).  
This qualitative review (i.e., Ross & Thomas, 2010) noted several important limitations 
with regards to the current literature on the study of the efficacy of yoga. Specifically, with the 
exception of one study (Oken et al. 2006), none of the studies included in the analysis used a 
randomized, controlled design to test their hypotheses (Ross & Thomas, 2010). Similarly, the 
authors noted that the studies did not specify which poses were included within their yoga 
protocol. This is an important limitation for two reasons. First, provision of a detailed yoga 
protocol can help future researchers replicate their findings to test if specific yoga poses are more 
beneficial than others and if so, for which symptoms they are more beneficial. Second, there are 
several different types of yoga (hatha, iyengar, ashtanga…etc.), which differ in their emphasis on 
the various components of yoga such as asana, breathing and meditation. Furthermore, there are 
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variations in the way certain poses are conducted (e.g., type, duration, speed) among these styles. 
The relative effects of these different aspects on the said health outcomes, and in particular 
anxiety symptoms for the purposes of the current study, have not been adequately answered thus 
far.  
 There are some practical reasons for advocating yoga as an alternative exercise modality 
as well. First, yoga does not require any special equipment, attire or accessories; and it can be 
practiced almost anywhere. Second, almost all yoga poses can be modified to meet the needs and 
restrictions of the practitioner. This means that almost all injuries and/or physical limitations can 
be accommodated in a yoga practice. These qualities make yoga a very practical health approach 
for managing a wide range of symptoms and for the purposes of the present study, particularly 
symptoms of anxiety. Therefore, determination of the specific characteristics (i.e., intensity, 
duration, style) of yoga that might render most beneficial for anxiolysis has significant potential 
benefits for this target population. Yet, despite these benefits, yoga as an exercise modality has 
not been extensively investigated in high-quality studies (i.e., randomized controlled designs 
conducted with individuals who experience anxiety symptoms at baseline). Furthermore, the 
published studies of this kind have not investigated vinyasa yoga which, given its higher 
intensity compared to other styles, is an ideal style to study for experimental models of anxiety. 
Finally, investigation of this relationship can initiate the attempts at trying to understand the 
mechanism(s) behind the anxiolytic effect of yoga. Ultimately, this is useful to understand why 
and how yoga (or other exercise modalities) induce its anxiolytic effects in prone individuals. 
Key issues in developing yoga protocols for research  
 Several issues need to be addressed with regards to the use of yoga protocols in research. 
Unfortunately, despite its increasing popularity and potential advantages as an exercise modality, 
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previous literature provides limited guidance to assist researchers in developing research and 
treatment protocols on yoga. Especially given the complex, multi-faceted (i.e., 8 different 
components) nature of this discipline, it is important to consider some key domains when 
developing testable yoga protocols for research purposes. A qualitative review discussing 
guidelines for developing such interventions (Sherman, 2012) stated that we currently lack the 
necessary empirical data for establishing robust, reproducible protocols of yoga and described 
eight domains to be addressed for accomplishing this in studies of efficacy testing: 1) style, 2) 
dose and delivery, 3) components, 4) specific class sequence, 5) dealing with modifications, 6) 
selection of instructors, 7) facilitation of home practice, 8) measurement of intervention 
adherence over time. These aspects should be decided on a priori based on the condition and the 
goals of the study, and provision of this information in publication is necessary for proper 
replication of the protocol by other researchers. This can subsequently allow for development of 
reproducible, effective yoga protocols for therapeutic purposes. Finally, these recommendations 
need to be considered within the context of the proposed study; that is, establishing the 
parameters of these domains for the development of the optimal yoga sequence for acute 
anxiolysis. 
Anxiety Sensitivity as a measure of symptom severity  
 It is important to delineate the differences between trait anxiety (TA) and anxiety 
sensitivity (AS) for the purposes of the proposed study, as they represent two different, but 
related constructs (Taylor, 1996; Taylor et al., 1991; Sandin et al., 2001). Theoretically, AS is 
linked to the underlying belief that anxiety symptoms have catastrophic consequences. 
Specifically, AS is the fear of anxiety and physical sensations related to anxiety, and the belief 
that the experiences of anxiety/fear and related physical sensations have harmful somatic, 
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psychological or social consequences (Reiss & McNally, 1985; Reiss, Peterson, Gursky & 
McNally, 1986). Therefore, when put in a stress-provoking situation, an individual with high AS 
is expected to experience greater levels of panic and overall anxiety symptoms in response to 
physical sensations triggered by the CO2-inhalation protocol, which is then more likely to set off 
a cycle that further exacerbates these symptoms (Bouton et al. 2001; Clark, 1986).  
 High AS has also been reported in individuals with generalized anxiety disorder (GAD; 
e.g., Deacon & Abramowitz, 2006) and in non-clinical worriers (e.g., Viana & Rabian, 2008). It 
is possible that the fear of uncontrollable psychological symptoms (i.e., worry) is characterized 
in both individuals with high AS and those with GAD (Rector et al., 2007). Consistent with this 
hypothesis, some studies suggest that GAD might be characterized by high AS cognitive 
concerns (Rector et al., 2007). Accordingly, the rationale for screening for AS is three-fold. First, 
it prevents the occurrence of possible floor-effects that have been reported as a systematic 
limitation in the literature on the anxiolytic effect of acute exercise (Ensari et al., 2015). Second, 
AS has been indicated to be a risk factor for ADs and panic disorders (McNally, 1990, 1996; 
Reiss, 1991; Sandin, Chorot & McNally, 1996; Taylor, Koch & Crockett, 1991; Taylor, Koch & 
McNally, 1992); and therefore is a strong predictor of whether the individual will respond to a 
CO2-inhalation challenge. Finally, previous studies have reported that self-reported AS score is a 
robust predictor of how likely an individual is to react to the presumably anxiogenic CO2-
inhalation task (e.g., Smits et al., 2009). Therefore, recruiting a sample with high self-reported 
AS levels can ensure that the participants are more likely show anxiety symptoms upon exposure 
to the 7.5% CO2-air mixture.  Accordingly, we targeted a sample of women who scored at least a 
25 on the Anxiety Sensitivity Index (ASI), which is ~1standard deviation (SD) above the 
population norm (i.e., 19). This cut-off score has previously been suggested as an indication of 
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“problematic anxiety symptoms” (Peterson & Phlemn, 1999; Taylor et al., 2007) and has been 
used by previous studies investigating exercise effects on anxiety as a cut-off point as well (e.g., 
Broman-Fulks et al., 2004).   
Carbon Dioxide (CO2) Inhalation Method as a Model of Anxiety 
 There are various experimental paradigms to study the human model of ADs, which 
attempt to induce acute anxiety symptoms that mimic real-life symptoms experienced by those 
with these conditions. Cognitive methods of anxiety induction include administration of stressful 
cognitive tasks, using anxiety-provoking vignettes and the Trier Social Stressor Test (TSST)). 
Biological methods of anxiety induction include administration of cholecystokinin tetra peptide 
(CCK4), infusion of sodium lactate, caffeine ingestion and the breathing CO2-enriched air 
mixture through a nasofacial mask or a mouthpiece. Of these methods, CO2-inhalation challenge 
has received considerable attention (Gorman et al., 2001; Van den Bergh et al., 1993; Eifert et 
al., 2003; Olantunji et al., 2009; Bernstein et al., 2009; Lejuez et al., 1998).  
 CO2-inhalation results in a range of acute physical (e.g. tachycardia, breathlessness, 
sweating, dizziness) and psychological (e.g. anxiety, nervousness, urge to escape, fear) 
symptoms. In general, concentrations of CO2 used in research with human subjects typically 
range from 2.2% to 65% CO2 mixtures, with higher concentrations of CO2 producing greater 
anxiety and panic symptoms. Similarly, duration of administration also varies among studies; 
with single and double inhalations often used to mimic panic symptoms and longer inhalations of 
up to 20 minutes utilized to mimic more generalized states of anxiety (Bailey & Nutt, 2008). The 
main advantage of using CO2-enriched air is that it is a safe, noninvasive, and reliable means of 
producing clinically-relevant sensations that remit within several minutes upon return to 
breathing normal room air. Furthermore, it produces symptoms that are similar to those observed 
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in individuals with anxiety disorders and that the administration can be safely and easily 
controlled. Consequently, it is frequently used as a realistic and valid model for studying anxiety 
response in humans without causing any permanent adverse effects. 
 There are 2 general clusters of conditions studied using the CO2-inhalation protocol; 
panic symptoms (i.e., for experimental modelling of panic disorders) and general anxiety 
symptoms (i.e., for experimental modelling of other types of anxiety disorders). The CO2-
inhalation protocol has been more commonly used for its ability to reliably induce panic like 
symptoms that complies with the formal criteria of a clinical panic disorder with just a single or 
double inhalation of 35% CO2-air mixture. On the other hand, fewer studies have investigated its 
ability to mimic more general anxiety symptoms to investigate the possible existence of similar 
effects on symptoms of GAD. To this effect, these studies have assessed the applicability of 
inhalation procedures that involve lower concentrations of CO2-air mixtures (e.g. 5%, 7%, 7.5%) 
inhaled for longer durations (e.g., 10-20 minutes). These studies have collectively reported that 
both clinical and community samples can display signs of generalized anxiety (e.g., Poma et al., 
2005; Bailey et al., 2005). Literature reviews on the CO2 challenge protocol (e.g., Colasanti et al. 
2012; Vickers et al., 2012) conclude that up to 20 minutes of 7.5% CO2 and a few breaths of 
35% CO2 are safe and reliable procedures for inducing symptoms of panic, distress and anxiety 
that resemble real life symptoms; as well as increased blood pressure and heart rate (i.e., 
increased autonomic arousal). As such, this model of anxiety has been used in psychiatric 
research for two decades without any unexpected adverse event (Bailey et al., 2008; 
Papadopoulos et al., 2008).  
 Application of the CO2 inhalation protocol provides further advantage with respect to our 
ability to assess the neurobiological basis of general anxiety symptoms. A variety of 
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neurotransmitter systems (e.g., gamma amino butyric acid; GABA, serotonin, epinephrine; NE, 
growth hormone; GH) have been investigated in an attempt to understand the central 
mechanisms that might be regulating CO2-induced anxiogenesis, and the serotonergic and 
GABA-ergic neurotransmitter pathways have received most support thus far. 
 There is converging evidence from experimental studies that the midbrain serotonergic 
neurons acting as CO2-chemoreceptors might be the underlying mechanism via which CO2 
inhalation might be inducing its effects (e.g., Bailey et al., 2007; Ben-Zion et al. 1999; Bocola et 
al., 1998; Corcoran et al., 2009). For example, one study (Bailey et al., 2007) reported that 
administration of paroxetine (a selective serotonin reuptake inhibitor; SSRI) inhibits responses to 
7.5% CO2; whereas other studies (Ben-Zion et al., 1999; Meiri et al., 2001) observed that 
serotonin antagonists effectively enhance the anxiety induced by CO2 inhalation. Similarly, a 
central role of the GABA-A receptor has also been proposed to explain CO2-induced 
anxiogenesis, based on findings from studies of benzodiazepines with clinical and volunteer 
participants. For example, in one proof-of-concept study comparing a full GABA-A receptor 
agonist (i.e., alprazolam), and a selective GABA-A receptor agonist (i.e., zolpidem) to a placebo, 
both drugs attenuated subjective feelings of anxiety and tension in response to the 20 minutes of 
7.5% CO2-inhalation (Bailey et al., 2008). These findings are in line with those of earlier studies 
that reported attenuated panicogenic effect of GABA-A receptor agonist (i.e., alprazolam) in 
response to 20 minutes of 7% CO2-inhalation in both individuals with panic disorders and 
healthy volunteers (Woods et al., 1986, 1989). Of note, even though the panic disorder (PD) 
participants in Woods et al. (1986) reported significantly reduced (p<0.05) somatic symptom 
(i.e., choking sensation, dizziness, hot/cold flashes, faintness, weakness) severity from pre- to 
post-inhalation after being treated with the GABA-A receptor agonist, there were no significant 
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changes in the ventilatory response (i.e., ΔVE/ΔpCO2) between treated and untreated 
participants. Specifically, there were no correlations between somatic symptoms during 
rebreathing and ventilatory response. This suggests that the locus of behavioral sensitivity to CO2 
in vulnerable individuals is likely some site other than the central chemoreceptors (Woods et al., 
1986). These findings are interesting because they are partially in contrast with those of another 
study (Bocola et al., 1998) that reported that at baseline, individuals with PD differed 
significantly in ventilatory response in comparison to healthy individuals, though the other 
ventilatory parameters were comparable. Furthermore, the control participants did not experience 
any significant panic symptoms in response to a 5-minute 7% CO2-air mixture inhalation 
(Bocola et al., 1998). A main limitation of these studies, for the purposes of the current study, is 
that they were conducted with individuals with PD, not GAD. Accordingly, these findings should 
be interpreted with caution and require further replication before reaching any conclusions.  
 In conclusion, application of a CO2-inhalation protocol for modeling GAD in a variety of 
experimental designs (e.g., exercise testing) has multiple advantages. First, it provides evidence 
for its feasibility for modeling real-life, sustained, GAD-like symptoms in volunteer participants. 
This can then allow researchers to use this protocol to assess the level of anxiety reduction of a 
multitude of potential anxiolytic methods for individuals with AS. Next, this method presumably 
affects the central nervous system directly, unlike other anxiogenic methods (e.g., lactate 
infusion), and therefore it allows for testing of the central neural mechanisms through which 
exercise could be inducing its anxiolytic effects. After it is validated in acute exercise studies, 
this protocol can be used in chronic exercise training studies in a pre-/post-intervention design to 
investigate if susceptibility to the anxiogenic effects of the CO2-inhalation protocol is alleviated 
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after exercise training. Collectively, these provide further justification for undertaking the 
proposed study. 
Acute exercise, CO2 Inhalation and Anxiolysis 
 To date, there have been only 5 published studies that investigate the anxiolytic effect of 
acute exercise in response to a CO2-inhalation challenge (Broman-Fulks et al., 2015; Esquivel et 
al., 2002, 2008, 2012; Smits et al., 2009). First, a pilot study (Esquivel et al., 2002) investigated 
the anti-panic effects of acute cycling at an intensity reaching >6mM of blood lactate elevation in 
healthy adults in response to a vital capacity single-inhalation of 35% CO2-air mixture. In the 
control condition, participants cycled at a “minimal” intensity (i.e., no elevation in blood lactate 
levels). The results indicated that participants in the active exercise condition reported attenuated 
panic responses after the CO2-inhalation challenge in comparison to those in the control 
condition. Interestingly, there were no correlations between blood lactate levels and the reduction 
in CO2-induced symptomology (Esquivel et al., 2002). However, this study has several 
limitations. First, the exercise control condition involved cycling, even though it was of 
“minimal exertion”, and so it is difficult to make an isolated attribution of the results to the 
cycling manipulation alone. Next, the exercise group had higher panic scores pre-CO2 inhalation 
than did the controls. Therefore, this higher baseline may have influenced the difference in CO2-
caused PSL increase. 
 The authors of this study undertook a follow-up study that investigated the anti-panic 
effects of acute cycling in response to a vital capacity single inhalation 35% CO2 inhalation 
(Esquivel et al., 2008). Eighteen patients with PD performed either moderate-vigorous intensity 
cycling or “very light intensity” cycling (i.e., control condition) on an ergometer. The duration of 
the exercise was variable; with the goal of the exercise stimulus being reaching 80-90% of their 
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age-predicted maximal heart rate (HRmax). On average, women exercised at 100W and men 
exercised at 150W, at 70rpm. Participants either exercised for 15 mins, or until exhaustion. The 
Visual Analog Anxiety Scale (VAS-A) and the Panic Symptom List-IV (PSL-IV) were used to 
assess panic symptoms before and after the CO2-inhalation challenge. A meaningful change in 
score was determined as a change of at least 4 points on the PSL-IV (Esquivel et al., 2008). The 
investigators also assessed blood lactate levels. The results indicated that the panicogenic 
response to CO2-inhalation was significantly attenuated after the moderate/vigorous cycling, in 
comparison to the very light cycling condition. Specifically, 3 out of 10 and 8 out of 8 
individuals in the exercise vs control conditions, respectively, had significant levels of increase 
on their PSL scores (Esquivel et al., 2008). Interestingly, the VAS-A scores were not 
significantly different between conditions (p>0.05). Finally, blood lactate levels were 
significantly increased after the moderate/vigorous intensity cycling (p<0.05), and this was 
comparable to the levels reached in previous studies in which participants received lactate 
infusions (Liebowitz et al., 1984). This is an important finding because there is some evidence 
that lactate can be anxiogenic (Cowley et al., 1988), and yet the self-reported measures on 
anxiety and panic symptoms were reduced in the moderate/vigorous cycling condition. This 
study has several limitations. In addition to the small sample size and the between subjects-
design, the exercise manipulation was not clearly described or based on an exercise prescription 
or rationale. Essentially, participants exercised at different intensities (the intensity was based on 
age-predicted HRmax) and of different durations (15 minutes or until exhaustion). There were also 
no standardized warm-up or cool-down periods built into the exercise. However, this study 
provides important preliminary data on the potential beneficial effects of acute exercise for 
improving panic and anxiety symptoms in clinical populations.  
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 The same authors conducted another follow-up study (Esquivel et al., 2012), 
investigating the antipanic effects of moderate/vigorous cycling (in comparison to a control 
condition of very light cycling) in response to a single or double inhalation of 35% CO2 air 
mixture. Thirty-one healthy participants completed 4 sessions in a randomized order: either 
moderate/vigorous or very light intensity cycling, and either 1 or 2 inhalation of 35%CO2 air 
mixture. All participants rated their anxiety and panic symptoms using the Visual Analog 
Discomfort Scale (for assessing discomfort), Visual Analog Fatigue Scale (for assessing fear) 
and the Panic Symptom List-IV (assessing acute panic symptoms). The results indicated that the 
symptom-reducing effect were largest in response to the 2 inhalation condition, based on the 
smaller increases in the fear and discomfort scores after the moderate/vigorous cycling condition 
in response to the double CO2-inhalation (p<0.05) (Esquivel et al., 2012). On the other hand, 
there weren’t significant differences in the post-exercise PSL scores between conditions 
(p>0.05); however, this might have been due to the baseline differences between groups. Finally, 
the results also indicated the when the effect of exercise alone was assessed, moderate/vigorous 
intensity cycling more effectively attenuated the panic and discomfort, but not fear (Esquivel et 
al., 2012). Similar to the findings from the previous 2 studies, this study also indicated that 
exercise alone increased the scores in the many items of the PSL related to physical symptoms 
that are in common with panic symptoms. Accordingly, this study suggests that the physical 
symptoms induced by exercise that mimic panic/anxiety are not necessarily accompanied by 
psychological symptoms of panic/anxiety. Collectively, these findings underscore the promise 
that exercise holds for effectively targeting clinical and subclinical symptoms of panic/anxiety 
without causing the individual any significantly perceived distress about their physical symptoms 
after exercise. 
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 A similar study was conducted with 92 individuals without history of panic attacks 
(Smits et al., 2009). In a between-subjects design, participants completed a single vital capacity 
inhalation of 35% CO2-air mixture before and after being randomized to either a 20-minute 
moderate-intensity (i.e., 70% of HRmax) treadmill walking condition or seated quiet rest. Gender 
and measures of negative affectivity (NA) and AS were included in the data analysis as control 
variables. The results indicated that exercise significantly reduced the anxiogenic response to the 
CO2-inhalation challenge after the exercise (p<0.05). Furthermore, the effect size remained in the 
moderate-to-large range (i.e., ηp²>0.07) even after controlling for gender, AS and NA. 
Specifically, the effects of exercise on response to challenge did not vary as a function of gender, 
but approached significance where women reported greater increase in symptom severity as a 
result of the challenge than men (p=0.07). Similarly, including cardiorespiratory fitness as a 
covariate did not change the observed results. Of note, the authors of this study have also 
demonstrated that AS appears to be a robust predictor of CO2 reactivity; that is, higher the scores 
on ASI, greater the panicogenic and anxiogenic response to CO2 inhalation challenge. This 
finding provides the rationale for consideration of ASI scores in the prospective sample for 
inclusion in the current study.  
 Finally, a recent study compared the relative effects of a single bout of aerobic vs 
resistance training on symptoms of panic and anxiety (Broman-Fulks et al., 2015) in healthy, 
sedentary individuals. Seventy-seven participants were randomized to complete 20 minutes of 
moderate-intensity (i.e., 70% of age-predicted HRmax) aerobic exercise (N=25), resistance 
training (N=26) or rest (N=26), followed by a single vital capacity inhalation of 35% CO2 air 
mixture. All participants completed the STAI-S, ASI, API, Distress Tolerance Scale (DTS) and 
the Discomfort Intolerance Scale (DIS) at baseline, after exercise/rest and after the 35% CO2-
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inhalation challenge. The results indicated that ASI scores were significantly reduced after both 
aerobic resistance exercise, with more than 20% of the aerobic exercisers and more than 25% of 
the resistance exercisers exhibiting a clinically meaningful decrease in AS and also significantly 
less reactivity to the CO2 inhalation (Broman-Fulks et al., 2015). The same pattern was observed 
on the API scores, with both exercise conditions resulting in comparable reductions in scores and 
reactivity (p=0.009 from baseline to post exercise, p<0.001 from post-exercise to post-CO2-
inhalation). There were no significant improvements on the other scales from pre- to post-
exercise (p>0.05). On the other hand, rest condition yielded non-significant trends toward larger 
increases (p=0.15 from post-rest to post CO2 inhalation) (Broman-Fulks et al., 2015). 
Interestingly, no significant interactions were observed on the scores of DIS, DTS and STAI-S 
(p>0.10 for all). This might suggest that the API and the ASI are more sensitive and applicable 
scales for measuring responses to panic/anxiety induced by inhaling CO2-air mixtures. 
Alternatively, it is possible that the construct of “distress” is not relevant for this type of 
protocol. An interesting aspect of this study is that authors administer the ASI, which measures a 
trait construct, acutely. It appears that the participants’ perceptions of their sensitivity to anxiety 
cues were slightly altered after the single exercise bout. This is unexpected, as by definition, trait 
measures are not expected to change in such a short amount of time or upon exposure to a single 
time-point event. Therefore, the results of this questionnaire should be interpreted with caution. 
Collectively, findings from this study provide further evidence acute exercise, regardless of 
modality (i.e., aerobic, anaerobic), can provide relief from symptoms of anxiety and panic in 
response to an acute stressor (i.e., CO2-air mixture inhalation).  
 Accordingly, there are several differences between these studies and the present study, 
and therefore possess limitations in their ability to examine the interactions between acute 
33	  
	  
exercise and GAD symptoms. First, all of these studies used an air mixture with a CO2 
concentration of 35%, which is a model of PD, but not GAD. This limits our ability to make 
inferences about the latter, as the literature agrees on the substantially different effects on the 
body when exposed the 35% CO2 concentration in comparison to lower (e.g., 7.5%) 
concentrations. Second, none of these studies measured delayed responses to the CO2 inhalation 
but instead only assessed it immediately post-condition. Therefore, there are currently no 
published data that describe exercise-induced delayed anxiolysis in response to a CO2-inhalation 
challenge. Third, cycle ergometer and treadmill walking are the primary exercise modalities 
employed in their designs, with only 1 of the studies (Broman-Fulks et al., 2015) using resistance 
training as one of the exercise conditions. Given the meta-analytic results that there is a 
disproportionate sample of published studies that use these modalities, alternative exercise 
modalities warrant further investigation for their potential anxiolytic effects. Another limitation 
is that 3 of these studies (Esquivel et al., 2002, 2008, 2012) did not use a no-exercise control 
condition. In these studies, the control condition consists of very light cycling at no resistance, 
which by definition, still constitutes exercise behavior, therefore limiting its ability to provide as 
a valid control condition for an exercise stimulus. Finally, it should be noted for these studies 
that the higher intensity cycling was significantly more effective than the very light cycling (i.e., 
control condition) for reducing the panicogenic response to the CO2-inhalation task, providing 
further evidence that higher intensities are more efficacious for reducing symptoms of anxiety 
and panic.    
Yoga and CO2 Inhalation and Anxiolysis 
 There are several mechanisms suggested in the literature to explain the anxiolytic effect 
of exercise. These include physiological models (e.g., thermogenic effect, endorphin hypothesis, 
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afferent affect) and cognitive/psychological models (e.g., self-efficacy, physiological toughness, 
the opponent-process theory, time-out hypothesis). These theories have been supported by 
research encompassing the past several decades (Petruzzello et al., 1991). The studies 
investigating these mechanisms have mostly used walking and cycling as the exercise modality 
in their designs and it is timely, given the increased interest and the practical aspects that these 
mechanisms are also tested using a well-designed, reproducible yoga protocol. While a direct 
assessment of such a causal mechanism is beyond the scope of the present study, it is important 
to discuss some possibilities as much as the current evidence allows.  
 A preliminary study by Streeter et al. (2010) investigated the changes in levels of GABA 
in the CNS after 12 weeks of iyengar yoga in comparison to walking. Yoga-naïve participants 
underwent proton-Magnetic Resonance Spectroscopy (pMRS) before and 12 weeks after the 
intervention, as well as for a 3rd time after completing a single session of yoga or walking after 
their 2nd scan. The results indicated that yoga was significantly and positively correlated with 
improved self-reported anxiety levels and also GABA concentration as suggested by the scan 
analyses (Streeter et al., 2010). Specifically, there was a 13% increase in the GABA levels after a 
bout of yoga when the participants have been trained for 12 weeks. This suggests that the 
physiological effects of yoga might be occurring later than the psychological effects experienced 
by the individual. Overall, this was first study to demonstrate that 1) increased thalamic GABA 
levels are associated with improved mood and decreased anxiety, and 2) yoga postures are 
associated with a positive correlation between acute increases in thalamic GABA levels. These 
findings are in line with others that investigate this relationship using pharmacological agents 
(Bailey & Nutt, 2008). The ability of yoga to induce these changes might be due to improved 
(i.e., increased) activity  in the parasympathetic nervous system (PNS), which is one of the 
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mechanisms previously proposed (Petruzzello et al., 1991). However, these interpretations 
should be made with caution as this study had some limitations. First, the acute bout of walking 
and yoga were done after 12 weeks of chronic exercise training, and therefore it is impossible to 
conclusive attribute these observed effects to the acute bout of yoga (or walking). Second, the 
intervention was semi-home based, such that participants were encouraged to practice on their 
own for the 2nd part of the intervention. During this time, participants averaged 1 session/week of 
yoga; therefore it is possible that with more frequent weekly sessions that there might have been 
larger effects observed in the 2nd time point assessment. Finally, in addition to the hypothalamus, 
there are other brain areas (e.g., raphe nuclei, midbrain periaqueductal grey (dPAG) have been 
implicated in anxiety and associated mood symptoms (e.g., depressive). Therefore, assessment of 
GABA in these areas might yield different patterns of change both over time and acutely.   
 The findings of Streeter et al. (2010) have further significance for the purposes of the 
current study. As mentioned earlier, one of the proposed mechanisms of the CO2-induced 
anxiolysis is that of GABA-ergic neurotransmitter system. That is, there is some evidence that 
inhaling CO2-enhanced air mixtures increase anxiety symptoms in sensitive individuals 
significantly influences GABA concentrations (Johnson et al., 2005; Nutt & Bailey, 2008). 
However, the results are not necessarily in the expected direction; these studies report an 
increase in GABA levels after CO2 exposure, which is in the opposite direction of previous 
studies that presumed that the anxiolytic effects were induced through an increase in GABA 
concentrations in the CNS. Collectively, these findings underscore the need for further research 
to delineate mechanisms through which acute yoga might be anxiety reducing and other mood-
improving effects. 
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 Desensitization to changes in respiration or an improved respiratory control induced by 
the acute yoga is another possible mechanistic explanation for why yoga might help attenuate the 
anxiogenic and panicogenic response to CO2-enriched air inhalation. This suggestion is based on 
a limited number of previous studies in the literature investigating the respiratory responses to 
inhaling air mixtures with similar CO2 concentrations (e.g., 7-7.5%).  For example, one such 
study investigated the respiratory responses to inhaling 15 minutes of 7.5% CO2-air mixture in a 
sample of 42 healthy adults and concluded that based on inter-individual differences, they could 
be separated into “high” vs “low” ventilation groups (Schaefer, 1958). That is, those classified as 
“low ventilators” had greater tidal volume (Vt) but lower respiratory rate (RR) than those 
classified as “high ventilators”. The group differences were also apparent in the physical 
symptoms reported by the participants (e.g., dizziness, headaches, dyspnea) and as such, these 
symptoms were reported considerably more frequently and intensely by the participants 
categorized into the “high” ventilation group. Similarly, another study investigated the 
respiratory response to 7% CO2-inhalation in patients with panic and anxiety disorders in 
comparison to healthy control participants (Papp et al., 1997). The authors reported that RR 
significantly increased in response to the inhalation task in the former group of individuals. 
These individuals were also reported to experience heightened respiratory sensitivity to the 
inhalation task (Papp et al., 1997). Collectively these studies indicate that individuals who 
possess cognitive worry (i.e., a primary feature of trait anxiety) may also be considerably more 
sensitive to changes in their breathing patterns (e.g., hyperventilation) and therefore respond with 
greater negative symptoms. Based on these prior reports, it would make sense to expect the 
sample in the current study to also exhibit similar symptoms. That is, that they would have 
relatively higher RR and lower Vt, which may potentially be amenable to acute change. 
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Accordingly, a breathing-focused physical exercise (i.e., vinyasa yoga), might be an ideal way to 
target these symptoms in this particular population. 
The Present Study 
 The present study is novel in several ways. First, the CO2-inhalation protocol as a 
biological human model of general anxiety and/or panic has never been investigated by inclusion 
of 2 time points after an exercise stimulus (i.e., immediately after and 1 hour after). Previous 
studies examining the anxiolytic effect of acute exercise have thus far only administered a single 
or double CO2-inhalation challenge immediately after the exercise stimulus (Esquivel et al., 
2002, 2008, 2012; Smits et al., 2009; Broman-Fulks et al., 2015). Investigation of whether the 
anxiolytic effects of a single bout of exercise sustains at later time points (i.e., 1 hour post-
condition) can help determine the duration of such anxiolytic effects and subsequently help 
inform future exercise study designs. Second, this is the 1st study to combine a longer breathing 
period (i.e., 5 minutes) and 7.5% CO2-air mixture to induce anxiety symptoms, with the 
exception of another, slightly modified study (i.e., Bocola et al., 1998) that used a 5 minute-
inhalation of 7% CO2-air mixture concentration. Previous studies have safely and successfully 
employed at least 1 of these components, but not both at the same time using a sample that has 
high baseline AS. The present study used a 7.5% CO2-air mixture based on previous studies that 
have successfully administered various CO2 concentrations below 20% as a proxy for anxiety 
symptoms (Van den Bergh et al., 1993; Eifert et al., 2003; Olantunji et al., 2009; Bernstein et al., 
2009).  
 Next, this is the first study that we are aware of that used vinyasa-style yoga, which is 
selected for its higher intensity in comparison to more commonly studied styles of yoga in the 
literature thus far (e.g. hatha, restorative, kundalini), as well as it is focus on synchronizing each 
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movement with an inhale or a exhale. Vinyasa yoga, also known as flow-yoga, coordinates 
breath patterns with a series of asanas (i.e., “1 move/breath”) and is therefore considered to be a 
more challenging form of yoga. During Vinyasa yoga, the practitioner moves from position to 
position while either inhaling or exhaling at a much faster pace than experienced in Hatha yoga 
(Cowen and Adams, 2007), or other styles (e.g., kundalini, iyengar). As an exercise modality, 
this faster pace makes vinyasa yoga a higher intensity form of exercise. Given the meta-analytic 
evidence that high intensity exercise is optimal for observing anxiolytic effects after an acute 
bout of exercise, it is evident that vinyasa yoga is an excellent candidate for efficacy testing. 
Furthermore, the present study took into account the published recommendations on how to 
design and implement yoga protocols for research purposes (Sherman et al., 2012). Based on 
these suggested guidelines, the following characteristics have been determined in the proposed 
yoga protocol: faster pace (i.e., in an attempt to achieve a moderate-to-higher intensity); a single, 
40 minute bout (i.e., acute, ecologically valid manipulation); components including asana, 
breathing and meditation (with the primary focus on the asana).  
 Similarly, the current study compared vinyasa-style yoga in comparison to an active 
control condition (i.e., light stretching). Previously conducted similar studies have not made such 
comparisons. We are aware of 1 study (Broman-Fulks et al., 2015) that compared resistance 
training to treadmill walking; and 1 other study that compared treadmill walking to a no-exercise 
control condition (Smits et al., 2009). The other 3 studies investigating the anxiolytic effects of 
exercise on the CO2-inhalation challenge have used a single cycle ergometer exercise stimulus 
(Esquivel et al., 2002, 2008, 2012). Furthermore, 3 of these studies (Esquivel et al., 2002, 2008, 
2012) have not employed a true no-exercise control condition.  Accordingly, the proposed study 
39	  
	  
aims to investigate the efficacy of such a yoga-exercise protocol in response to a biological 
anxiogenic (i.e., CO2-inhalation) in a randomized, controlled study. 
 Finally, none of the previous 5 studies have used a women-only sample to test their 
anxiolysis hypothesis, which accordingly limits our ability make inferences regarding women 
based on their findings. This is an important gap in the literature to address for 2 reasons. First, 
given the significantly increased prevalence of ADs and anxiety symptoms in women compared 
to men, a greater emphasis on women samples is justified. Second, there is some evidence that 
menstrual cycle phase influences the response to the CO2-inhalation challenge, but only among 
women with high AS. Specifically, it has been reported that women who score high on AS report 
increased cognitive panic symptoms in response to the challenge during the premenstrual phase 
compared to the follicular phase, and compared to women who score lower on AS assessed in 
either cycle phase (Nillni et al., 2012; Perna et al., 1995). Given the small body of currently-
existing research on this topic, and the general under-representation of women in health research 
that is often attributed to difficulty of controlling for hormonal fluctuations, it is timely to include 
this variable in an experimental design that investigates a mood outcome measure (i.e., anxiety) 
that affects women twice as much as men. 
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CHAPTER 3: METHODS AND MATERIALS 
Participants 
 Prospective participants were identified from the University of Illinois at Urbana-
Champaign campus with the goal of recruiting 18 women participants in total. Sample size was 
selected based on previously conducted studies of CO2-inhalation and anxiety (Bailey et al., 
2007; Diaper et al., 2012). These studies indicated that for a within-subjects study of anxiolytic 
effects on 7.5% CO2-inhalation, to detect a significant difference at alpha=0.05 level, and a 
sample size (N) of 13 would be required. To allow for variation in parameters (i.e., to control for 
potential baseline trait differences), increasing this number to 18 has been recommended (Diaper 
et al., 2012). Fliers advertising the study were distributed through classes not taught by any 
members of the experimental team. Fliers were also posted on bulletin boards in the common 
campus spaces, such as building hallways. Once a prospective participant expressed interest via 
email or phone, the study protocol was described to them via telephone. If the individual was 
interested, the screening for the following inclusion criteria were carried out: (a) women between 
18 and 54 years of age; (b) willingness and ability to do yoga poses and complete multiple mood 
assessments; (c) a score of 25 or higher on the ASI (indicating clinically meaningful anxiety 
sensitivity); (d) no current use of drugs, cigarettes or psychotropic medication or adrenergic 
blockers; (e) no history or current diagnosis of asthma or other breathing-related disorders; (f) 
willing to avoid any caffeine, alcohol and moderate-to-vigorous exercise 12 hours prior to each 
testing session; (g) not pregnant, lactating or having plans of getting pregnant in the next 6 
months; (h) no current or history of panic attacks, (i) no current or history of alcohol or drug 
abuse, (j) no current or history of medical conditions that might be aggravated by study 
procedures (e.g., yoga, CO2-inhalation protocol) including cardiovascular disorders (e.g., cardiac 
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arrhythmia), renal disorders, respiratory disorders (e.g., asthma, lung fibrosis), high blood 
pressure, epilepsy, stroke or seizures; (k) not practicing yoga for more than 2 times a week for 
the past 6 months; (l) no current or past experience of panic attacks and (m) no abnormal resting 
or exercising electrocardiogram (ECG) diagnosed by a clinician, (n) low risk for 
contraindications of maximal exercise testing. The low risk for contraindications was based on 
no more than a single “yes” response on the Physical Activity Readiness Questionnaire (PAR-
Q).  
 This study targeted women with self-reported AS (via the study advertisement distributed 
across the campus) to increase the probability of recruiting a sufficient sample of women who 
adequately respond to the CO2-inhalation protocol (i.e., to avoid floor effects). This was based on 
the previous findings that the ASI score is a strong, reliable predictor of CO2-reactivity (Broman-
Fulks et al., 2015; Smits et al., 2009). This method for identification of the desired sample has 
been used by previous studies (Broman-Fulks et al., 2004) and has been suggested as indication 
of “possible problems” with respect to anxiety symptoms (Peterson & Plehn, 1998; Peterson and 
Plehn, 1999). Accordingly, only individuals whose self-reported ASI scores during the screening 
were 25 or higher were enrolled based on this inclusion criteria. A score of 25 or higher is ~0.75 
SD above the population norms for adults (i.e., 19) and has been suggested as indicative of 
clinically meaningful AS (Taylor, 1982). Furthermore, to account for the possible effects of the 
hormones on the anxiogenic responses to the CO2-air mixture, the phase of the menstrual cycle 
was accounted for (i.e., luteal vs non-luteal), which was based on the approach previously used 
by other researchers (i.e., Perna et al., 2005). Finally, participants were instructed to abstain from 
alcohol, caffeine, and any moderate-to-vigorous physical activity starting 12 hours before each 
session.  
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Baseline assessment measures.	  
1. Spielberger State-Trait Anxiety Inventory (STAI).	  The STAI (Spielberger et al., 1983) has 2 
subscales (Trait and State Anxiety subscales) that measure overall (i.e., “Trait”) and current (i.e., 
“State”) anxiety levels in respondents. Both subscales have 20 items that are rated on a scale of 1 
to 4 and the total scores range from 20 to 80, with higher scores indicating greater frequency of 
trait and state anxiety. It is one of the most commonly used anxiety assessment scales to date and 
it can be used in both clinical and community samples. It has demonstrated good internal 
consistency, test–retest reliability in the STAI-Trait subscale, sensitivity to detection of stress in 
the STAI-State subscale, and convergent and discriminant validity (Barnes et al., 2002; 
Hishinuma et al., 2000; Kabacoff, Segal, Hersen, & Van Hasselt, 1997; Spielberger, 1989; 
Vautier, 2004).  
2. Hospital Anxiety Depression Scale (HADS). The HADS (Zigmond & Snaith, 1983) will be 
used to assess general symptoms of anxiety and depression. The HADS contains 14 items; 7 
items measure anxiety and 7 items measure depression. Total scores range from 0 to 21 for each 
subscale and higher scores indicate greater frequency of anxiety and depression symptoms in the 
past 2 weeks. A cut-off score of 7 has been suggested to indicate clinically meaningful levels of 
anxiety and/or depressive symptoms.  
3. Anxiety Sensitivity Index (ASI). The ASI is a 16-item self-report measure designed to assess 
fear of anxiety sensations. It includes items such as ‘‘When I notice that my heart is beating 
rapidly”, “I worry that I might have a heart attack,”, ‘‘When I am nervous, I worry that I might 
be mentally ill.”). Items are rated on a 5-point Likert-type scale (0= very little to 4=very much). 
Initial evaluation of the ASI has indicated that it possesses sound psychometric properties, 
including good alpha scores (ranging from .78 to .91) and adequate convergent, discriminant, 
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and criterion-related validity (Peterson and Reiss, 1992; Reiss et al., 1986). This scale was used 
during screening to target and enroll individuals who score a 25 or higher on the scale (i.e., ~1 
SD above the population norm and indicative of clinically meaningful anxiety sensitivity). 
4. Spielberger State-Trait Anger Expression Inventory (STAXI). The STAXI (Spielberger et al., 
1988) includes five subscales: State Anger (15 items), Trait Anger (10 items), Anger-in, Anger-
out, and Anger Control (8 items each). The Trait Anger subscale assesses the appraisal of one’s 
typical mood (e.g., “I am quick tempered”) with items evaluated in terms of their frequency 
(ranging from 0= Almost Never to 3= Almost Always) whereas the State Anger subscale (SAS) 
assesses current mood (e.g., “I am furious”) with items evaluated with respect to their intensity 
(ranging from 0= “Not at all” to 3=”Very much so”). The SAS possesses high internal 
consistency coefficients (ranging from .86 to .95) and good convergent and discriminant validity 
(Spielberger, Gorsuch, Lushene, & Jacobs, 1983). The other 3 subscales (i.e., Anger-in, Anger-
out, and Anger Control) include 8 items each that rated on a scale of 0 (“Not at all”) to 3 (“very 
much so”) with higher overall scores indicating higher frequency of symptoms. All 3 subscales 
have been reported to be internally consistent and able to assess responses to hypothetical anger-
provoking scenarios (Spielberger, 1988).  
5. Generalized Anxiety Disorder Scale (GAD-7) The GAD-7 is a 7-item self-reported measure of 
frequency of GAD. Each item is scored on a scale of 0 (“not at all”) to 3 (“Nearly every day”) 
based on the presence of symptoms in the past 2 weeks. Higher scores indicate higher frequency 
of anxiety symptoms. The GAD-7 has been reported to have strong criterion validity for 
identifying probable cases of GAD and ability to assess symptom severity, as indicated by the 
strong positive correlations between the scale scores and functional impairment (Spitzer et al., 
2006). Scores of 5, 10, and 15 have been suggested as reasonable cut points representing mild, 
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moderate, and severe levels of anxiety (Spitzer et al., 2006). Finally, the scale has good test-
retest reliability, as well as criterion, construct, factorial, and procedural validity (Spitzer et al., 
2006). 
6. Trait Mindfulness And Attention Scale (MAAS-T). The MAAS-T is a 15-item self-reported 
measure of trait mindfulness, which is defined as “a receptive state of mind in which attention, 
informed by a sensitive awareness of what is occurring in the present, simply observes what is 
taking place” (Brown and Ryan, 2003). Each item is scored on a scale of 1 (almost always) to 6 
(Almost never). Total score is calculated by averaging all the items and higher scores reflect 
higher levels of trait (i.e., dispositional) mindfulness. It has been validated for use in a variety of 
samples including college students, community adults (Brown & Ryan, 2003), and for 
individuals with cancer (Carlson & Brown, 2005). Internal consistency levels (Cronbach’s 
alphas) generally range from .80 to .90. The MAAS has demonstrated high test-retest reliability, 
discriminant and convergent validity, known-groups validity, and criterion validity (Brown & 
Ryan, 2003; Carlson & Brown, 2005; Siegling & Petrides, 2013). The MAAS-T is one of the 
most commonly used scales to measure mindfulness and it has been used in samples with 
depressive and/or anxiety symptoms (e.g., Baer et al., 2006; Christopher & Gilbert, 2010). The 
scores on the MAAS-T were accounted for when assessing the responses to the CO2-inhalation 
task. This allowed us to assess whether higher trait mindfulness is associated with more 
attenuated anxiety symptoms when exposed to this anxiogenic task. 
7. Anxiety Sensitivity Index-3 (ASI-3). The ASI-3 (Taylor et al., 2007) is an 18-item, revised 
version of the 16-item original ASI. There is some preliminary evidence that the revised scale 
might have better psychometric properties than the original, 16-item scale (Taylor et al., 2007). It 
measures 3 components of AS: cognitive, psychological and physical anxiety. Cut-off scores of 
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23and 17 have been recommended by previous researchers for identification of high and 
moderate-to-high AS individuals, respectively (Allan et al., 2014). It has been validated for use 
in both healthy and clinical samples (Kemper et al., 2011; Olthius et al., 2002). Participants filled 
out this questionnaire during the baseline session (unlike the original ASI, which is used as a 
screening questionnaire). This served 2 purposes. First, it allowed for comparison of responses 
between the 2 scales among participants. Second, it allowed for determination of whether 
participants vary their responses when reporting verbally to somebody else (i.e., the 
experimenter/screener) versus in writing in person.  
Primary outcome measures 
1. Acute Panic Inventory (API) (Liebowitz et al., 1984) consists of 17 items that assess the 
presence of current panic-related symptomology using a 4-point Likert-type scale (0=not present 
to 3=severe). These are primarily somatic symptoms such as palpitations, rapid or difficulty 
breathing, or sweating. The API is one of the most commonly used questionnaires in studies that 
involve inducing panic symptoms and CO2 challenges (e.g., Colasanti et al. 2012; Broman-Fulks 
et al 2015). Finally, it has sound psychometric properties (Liebowitz et al., 1984). The API has 
been indicated to be robust in differentiating panic attacks from other forms of stress and anxiety 
Dillon et al., 1986). This scale will be used in the current study to allow for making distinctions 
between panic-specific and more general anxiety symptoms experienced by the participants. 
2. The 20-item Spielberger State Anxiety Inventory (SAI). The psychometric properties of the 
STAI have been described above (Spielberger, 1983). Each item is rated on a 4-point Likert-type 
scale (1=not at all to 4=very much so), with overall scores ranging from 10 to 40.  Higher scores 
indicate higher levels of current/state anxiety.  
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3. The Spielberger State Anger Subscale (SAS). The SAS is described above.  
4. Visual Analog Scale-Anxiety (VAS-A). The VAS-A is a 1-item scale that is rated on 100 mm 
line, anchored from 0 (‘‘not at all’’) to 100 (‘‘the most ever’’). These types of scales have been 
indicated to provide a good estimate of the rapid changes in aspects of mood states (Bond and 
Lader, 1974). The VAS-A has been validated to effectively capture acute changes in anxiety in 
clinical populations (Williams et al., 2010). In addition, it is a quick and easy way of assessing 
such changes while the participant is engaging in a potentially uncomfortable activity (i.e., 
breathing CO2-enriched air mixture through a mouthpiece) that might make filling out 
questionnaire more difficult and distracting. An increase of at least 25% on the VAS-A has been 
reported to be indicative of significant clinical symptoms of panic and anxiety (Klaassen et al., 
1998). 
Other Outcome Measures 
State Mindfulness And Attention Scale (state MAAS). The state MAAS is a 5-item scale designed 
to assess the short-term or current expression of a core characteristic of mindfulness (Brown & 
Ryan, 2003). The state MAAS includes items drawn from the MAAS-T (e.g., “I’m finding it 
difficult to stay focused on what’s happening in the present”). As opposed to the MAAS-T, the 
state version addresses the questions based on a specific time point (i.e., “at the time of ____”), 
therefore allowing the experimenter to assess mindfulness in relation to a specific task (e.g., 
while doing yoga). Each item is scored on a scale of 0 (Not at all) to 5 (very much) and the 
overall state MAAS score is calculated by averaging the sum of the individual item scores. It has 
been reported to have adequate psychometric properties (e.g., Cronbach’s alpha = .92) and has 
been validated for use with college student and community adults (Brown & Ryan, 2003). Trait 
MAAS scores have been reported to predict state MAAS scores, which in turn have been 
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associated with psychological wellbeing outcomes (Brown & Ryan, 2003). Accordingly, there is 
evidence for both the construct and incremental validity of the state measure. This scale was used 
to assess the level of mindfulness experienced by the participants during the yoga vs stretching 
sessions.  
Respiratory outcomes. Expired air during the CO2-inhalation procedure was collected via a 
computer-based ventilatory expired gas analysis system (TrueOne 2400, ParvoMedics, Sandy, 
UT). This allowed the experimenter to collect data on changes in respiratory response to the 
CO2-inhalation task before, immediately and 1 hour after the intervention (i.e., yoga or stretching 
control). Specifically, tidal volume (Vt), respiratory rate (RR), ventilation (VE), and CO2 
production (VCO2) were monitored. They were assessed both as peak values reached during the 
final minute of the inhalation task and for a more comprehensive response profile, as 30-second 
intervals of the entire inhalation period (i.e., 5 minutes). 
Manipulation checks 
 Heart Rate (HR) and Ratings of Perceived exertion (RPE). HR and RPE were monitored during 
the yoga and stretching sessions to assess the intensity of the sessions. Accordingly, these 2 
variables served as manipulation checks for the a priori-determined moderate intensity level for 
the yoga session and the very light intensity level of the stretching (i.e., active control) session.  
Fraction of expired CO2 (FECO2). FECO2 was monitored as a way to confirm the 7.5% CO2 
inhaled. That is, it served as a manipulation check for the enhanced CO2 concentration that the 
participants were breathing an air mixture with ~7.5% CO2. Therefore, it was expected to 
increase to at least 7.5% during these time points.  
Procedures and Experimental Sessions 
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 The procedures were approved by the University of Illinois Institutional Review Board 
and all participants provided written informed consent. The timeline of study events is provided 
in Figure 1. The study procedures consisted of 3 testing sessions conducted in our laboratory and 
each session was separated by one week. The first testing session was a baseline session, and the 
other sessions (i.e., sessions 2-3) consisted of the experimental conditions (i.e., yoga and 
stretching). Each session lasted approximately 2 hours. Participants received a remuneration of 
$10 for baseline and $20 for each experimental session for a total of $50. In the event that they 
do not complete a session, remuneration was prorated. 
During the baseline session, participants first underwent the CO2-inhalation task. The 
purpose of this 1st trial was to habituate the participants to the procedure and accordingly to 
avoid an anticipatory effects (i.e., a falsely exaggerated anxiety/discomfort response in 
anticipation of the task). Accordingly, they were asked to provide current mood symptoms pre- 
and post-inhalation using the 4 state mood questionnaires (SAS, SAI, VAS-A, API). Afterwards, 
they completed a battery of baseline questionnaires on mood (i.e., STAI, STAXI, HADS, GAD-
7, VAS-A, API, ASI-3, MAAS-T), as well as information on demographics, and medication use. 
We also collected data regarding the menstrual phase of the participant, as this factor has been 
previously indicated to be influential on the anxiogenic response to the CO2-inhalation protocol 
in high AS individuals (Nillni et al., 2012; Perna et al., 1995).  
CO2-inhalation protocol. After being seated in a comfortable chair, participants were 
given a standardized set of instructions regarding the CO2-inhalation protocol: “Next, we will do 
the CO2-inhalation task. This task involves you wearing a mouthpiece and a nose clip similar to 
the one you wore during the IET. You will be breathing through this mouthpiece for the next ~3 
minutes. It is important that you continue to take normal, full breaths during this period and not 
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try to hold your breath. You will first be breathing ambient air to get familiarized with the task. 
After 30 seconds, you will start receiving CO2-enriched air that may produce physical and 
mental sensations, such as racing heart, sweaty palms, dizziness and out of breath. These are 
common symptoms during this task and we will be asking you to rate your overall anxiety level 
on the visual scale after each minute of breathing the CO2-enriched air. As a reminder, you can 
terminate this task by simply removing the mouthpiece if you feel unbearable discomfort. Since 
you will have the mouthpiece in, you will not be able to talk. So please ask any questions you 
might have before we begin”. Afterwards, participants were fitted with a 3-way T-shaped 
mouthpiece (Hans-Rudolph, Kansas) and a nose clip. The inhalation-end of the mouthpiece will 
be attached to a breathing tube that is connected to a 100-Liter Douglas bag. The Douglas bag 
was attached to a 3-way T-shape stopcock (Hans-Rudolph, Kansas) that is connected to a gas 
canister filled with 7.5% CO2/ 21% O2/ 71.5% N mixture (Airgas Inc., IL) via a breathing tube. 
The 3-way stopcock has a valve switch that allows the experimenter to control the air flow 
between the gas canister, Douglas bag and the mouthpiece via breathing tubes. The exhalation-
end of the mouthpiece was attached to a pneumotachograph/integrator system (Parvo Medics 
TrueOne 2400, Sandy, UT) to monitor breathing patterns and measure exhaled gases. The first 
30 seconds of the inhalation procedure served as the habituation period during which participants 
breathed ambient air. The purpose of this was to get the participants habituated to the breathing 
procedure through the mouthpiece and ensure proper breathing without letting any air leak out of 
the mouthpiece. Similar habituation methods have been used by previous studies (Pappens et al. 
2012; Seddon et al., 2011) for this purpose. At the end of the habituation period, the 
experimenter switched the stopcock valve so that the participant started breathing the 
decompressed 7.5% CO2-air mixture from the gas collection bag for the next 5 minutes. Previous 
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studies have used a wide range of durations for this protocol (i.e., 90 seconds to 20 minutes) and  
durations of around 5 minutes have previously been successfully and safely used (Pappens et al., 
2012) without any adverse, sustaining side-effects for the participant.  At the end of each testing 
session (i.e., after 3rd CO2-inhalation task), participants were asked to stay seated until they felt 
well enough to leave the research laboratory. Previous studies have reported that participants 
return to baseline levels within several minutes upon termination of the CO2-inhalation challenge 
regardless of the CO2 concentration or the duration of the breathing (e.g., Kaye et al. et al., 2004; 
Pappens et al., 2012, Bullis et al., 2010, Dripps & Comroe, 1946, Ben-Zion et al., 1999). 
Combined with our experiences from the pilot-testing of our protocol, we expected this time 
period to be no longer than 5 minutes. The experimenter stayed with the participant during this 
period to ensure the safety and well-being of the participant and also checked their heart rate to 
make sure that the participant’s heart rate has gone back to baseline. As expected, none of the 
participants required extra time to recuperate and were able to leave the research facilities soon 
after (i.e., within 5 minutes) the termination of the study.  
Experimental conditions. The subsequent experimental conditions (i.e. sessions 2-3) 
occurred in a within-subjects design and the order of sessions were randomized and 
counterbalanced across participants. Participants initially completed the same state mood battery 
of questionnaires on anxiety, anger and panic symptoms (i.e., SAS, SAI, VAS-A, API) while 
seated in a comfortable chair before and after the 1st inhalation task. Participants then completed 
the assigned experimental condition (i.e., guided yoga, or light stretching) and complete the same 
battery of questionnaires again within 5-minutes after the condition (i.e., immediately post-
condition), as well as the state MAAS (i.e., MAAS-S). At this point (i.e., immediately after the 
yoga/stretching protocol, before the 2nd CO2-inhalation task), participants were also asked to 
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report their peak RPE (i.e., “the highest level of exertion they felt during the session”). After the 
2nd inhalation task, participants completed the same battery of questionnaires. For the assessment 
of delayed response to CO2-inhalation task, participants then went through a waiting period of 
~40 minutes (i.e., 1 hour from the end of yoga/control condition), followed by a final CO2-
inhalation task and completion of the same battery of questionnaires pre- and post-inhalation 
procedure.  
Yoga intervention. The yoga session began with 5 minutes of meditation/deep breathing, 
20 minutes of Vinyasa yoga, and ended with a 5-minute period of “Savasana” or “Corpse Pose”. 
The specific sequence was determined based on: 1) ecological validity, i.e., most commonly used 
poses in a community vinyasa yoga class, 2) the fundamentals of this type of yoga (e.g., sun 
salutations), 3) logical sequence that can be delivered with safety within 40 minutes (e.g., 
avoidance of any poses that might be too advances for a beginner and therefore become 
unsafe/hazardous). Finally, modifications were offered on a per need basis. That is, every pose in 
the sequence in the proposed study included a priori-determined alternative without 
compromising the main goal of the pose. Therefore, in the event that a participant was unable to 
carry out a pose in the way it is originally intended, they would still be able to participate and do 
it to the best of their ability. However, none of the participants enrolled in the study required any 
modifications, except for the use of a block to sit on during the meditation/deep breathing part at 
the beginning for some of the participants. 
The Vinyasa yoga sequence started with cat and cow poses (i.e., spinal warm-up on 
hands and knees), followed by several repetitions of sun salutations A and B each. Following the 
sun salutations, sequences included the fundamental poses that form the majority of the 
sequence: Tadasana (Mountain Pose), Urdhva Hastasana (Upward Salute), Uttanasana (Standing 
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Forward Bend), Low Lunge (Anjaneyasana), Plank Pose, Chaturanga Dandasana (Four-Limbed 
Staff Pose), Bhujangasana (Cobra pose), Urdhva Mukha Svanasana (Upward-Facing Dog Pose), 
Adho Mukha Svanasana (Downward-Facing Dog Pose)); and ended with a series of other 
postures (i.e., child’s pose, warrior-1, warrior-2, extended side-angle pose, forward bends, seated 
twists, balancing poses) that involve isometric muscle contraction and relaxation of different 
muscle groups in conjunction with regulated breathing. These poses are among the most 
commonly practiced poses by yoga practitioners and therefore were selected based on their 
ecologic validity with respect to the traditional vinyasa yoga classes offered at a regular yoga 
studio. Participants mirrored the yoga instructor (i.e., the experimenter), who performed the 
postures for the participants and guided them throughout the sequence, as well spotted them 
when necessary. Yoga blocks and bolsters were provided for the participants; they were further 
assisted by the experimenter if and when necessary. The intensity during each acute yoga session 
was monitored based on the assessment of HR using a Polar heart rate monitor (Polar Electro 
Oy, Finland)) and the RPE scale. HR was recorded every 10 minutes and RPE was recorded at 
the end of the session by asking the question “At the peak of the session, how hard were you 
working?” to the participant at the end of the session. The yoga protocol was developed based 
several factors. First, the sequence was created so that it closely mimics a traditional vinyasa 
yoga class that is offered at a community yoga class. Next, the included poses are considered 
fundamental in this style of yoga (e.g., doing a vinyasa between every pose, matching the pace of 
the breath to the pace of the pose). Similarly, attention was given to provision of a well-rounded 
protocol by including a variety of poses that are meant to target different components of yoga 
(e.g., balance, stretching, endurance) based on the teachings of commercially published books on 
yoga sequencing (e.g., Stephens, 2012). Finally, the protocol took into account previously used 
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yoga sequences for other research projects in our research laboratory (e.g., Sandroff, 2015), 
which had been developed in collaboration by the experimenters and a licensed yoga teacher 
who works as a yoga instructor at yoga studios across the United States. The session was 
delivered to the participants on a one-on-one basis by the experimenter (IE) who has 6 years of 
experience as a yoga practitioner and 3 years of experience as a meditation and stretching 
instructor assisting both healthy individuals and those with neurological diseases (i.e., multiple 
sclerosis).  
Control condition. The control condition involved the participants completing a 
stretching protocol involving movement, attention and social contact for 40 minutes to match the 
active yoga condition. This is an active form of control condition and is considered to be ideal in 
mind-body and exercise studies as it more closely mimics the active condition (Kinser and 
Robbins, 2013). Therefore, this allowed for the attribution of any observed difference in the 
inhalation task responses to the active yoga component. Second, this has been suggested in the 
literature as a more ethical approach as it allows the participants to receive similar treatments and 
also similar amounts of attention and interaction from the experimenter under both conditions 
(i.e., experimental and control) (Kinser & Robbins, 2013). 
During the 40-minute stretching protocol, participants did some light stretching either 
while sitting or lying on the floor (e.g., body twists, leg/hamstring stretches, arm and shoulder 
stretches), as well as some sitting and lying poses that resemble the breathing meditation 
component provided in the yoga condition. However, no instructions on any type of yogic or 
otherwise meditative breathing were given or mentioned to the participant. The stretching poses 
have been previously used in exercise training studies in our research laboratory with other 
populations (i.e., multiple sclerosis). This is an ecologically valid control condition for studies of 
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acute exercise and mood, as it accounts for the social aspect of the intervention, as well as the 
passage of time and its potential transient effect on mood. 
Post-condition CO2-inhalation protocols and the resting period. The CO2-inhalation 
protocol has been described above and the same steps were followed for the administration 
immediately post- and 1 hour-post condition. Participants were then given a seated resting period 
of approximately 40 minutes between the 2nd and 3rd inhalation tasks (i.e., 1 hour between the 
end of the intervention and the 3rd inhalation task). During this time, they were seated in a 
comfortable chair in the main research area and were allowed to read materials provided by the 
research team, use their cellphones for communication purposes only (i.e., using the internet or 
listening to music were not allowed) and use the restroom if needed. At the end of the resting 
period (i.e., 1 hour post-condition), participants went through the CO2-inhalation protocol for a 
2nd time, preceded and followed by the completion of the same battery of questionnaires. This 
marked the end of the study session. The experimenter followed the protocol described above 
regarding the release of the participant from the research facility. 
Data Analysis 
 All data analyses were conducted using SPSS v. 22.0. Descriptive statistics for 
demographic and clinical characteristics are provided as mean (SD) throughout text, table and 
figures. Separate 2(condition) ×	 3(assessment time point) ×	 2 (pre- and post-exposure) repeated-
measures analyses of variance (ANOVAs) were conducted for identifying the interactions and 
main effects of assessment time point (pre-, immediately post-, 1-hour post-condition) and 
condition (yoga and light stretching/control) on self-report measures of anxiety, panic, and anger 
from pre- to post-exposure (i.e., CO2-inhalation task). Respiratory data (i.e., Vt, RR, and VE) 
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were analyzed 2 separate ways: First, by taking the peak value from the last minute of the 
inhalation task (i.e., between minutes 4 and 5) and second, by taking the 30-second averages of 
the entire 5-minute exposure period to capture a more comprehensive profile of the fluctuations 
during this task. Accordingly, separate repeated measures ANOVAs were conducted for both 
sets of analyses and are reported in text (condition: yoga, control; × assessment time point: T1, 
T2, T3) and tables (condition: yoga, control; × assessment time point: T1, T2, T3; x ten 30-
second intervals over entire task). Finally, effect sizes (ES) were computed as partial eta squared 
(ηp²) for all scores reported in the ANOVAs and the suggested norms of 0.01 (small), 0.06 
(medium), and .14 (large) for determination of the size of the ES (Field, 2013). 
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CHAPTER 4: RESULTS 
Participant recruitment and enrollment 
 A total of 93 women contacted our research laboratory via email or phone expressing 
interest in potentially participating in the study. These individuals were provided with more 
details on the study, as well as the informed consent document. Of those, 46 individuals 
expressed further interest and were screened based on the previously described list of screening 
criteria. Twenty-four individuals were qualified. Two individuals decided not to continue after 
the screening due to the time commitment required and therefore 22 participants were scheduled 
for testing. Of these, 3 participants could not complete the full 5 minutes of breathing of the 
7.5% CO2-air mixture during the baseline session and were therefore disqualified. One 
participant dropped out after the 1st experimental session due to time-commitment issues. 
Accordingly, 18 participants completed the entire study and so the final sample size for the data 
analyses is 18 women with a score of 25 or higher on the ASI. 
Participant characteristics 
 The sample had a mean age of 22 years (SD=5); 16 of the participants were 
undergraduate students on the university campus. Eleven participants (i.e., 61%) were using a 
hormone-based birth control method (e.g., pill or shot), and there was an even split in the 
menstrual cycle phase of the participants at the time of their testing (i.e., 9 on the luteal phase 
and 9 on the non-luteal phase). The mean score on the ASI was 32.2 (SD=6), which is 
approximately 2 SD above the normative value for the general adult population (i.e., 19). On the 
other hand, the mean score on the ASI-3 was 24.9 (SD=10.3). A score of 17 on the ASI-3 is 
considered having moderate-to-high AS and a score of 24 or higher is considered having high 
ASI. Accordingly, we have successfully managed to recruit a sample of women with clinically 
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meaningful levels of trait sensitivity for anxiety and panic symptoms. The mean score on the 
GLTEQ was 40.9, which is considered highly physically active and meeting physical activity 
guidelines (PAGs) according to published guidelines (USHHS, 2013). The mean score on the 
MAAS-T was 3.8 (.9), which is very close to the normative mean score reported for college-aged 
adult populations (i.e., M=3.8, SD=.7) (Brown and Ryan, 2003). The mean score on the TAI was 
46.4 (SD=10.3), which is approximately 1.4 SD above the population normative score reported 
for adult women (i.e., M=34.8, SD=9.2) (Spielberger et al., 1983). The mean HADS-D score was 
5.2 (3.9) and the mean HADS-A score was 9.8 (4.7). The cut-off score on the HADS for 
clinically meaningful anxiety or depressive symptomology is considered 7; accordingly, the 
sample had clinically meaningful levels of anxiety symptoms, but not depressive symptoms. The 
mean GAD-7 score was 8.4 (SD=4.8), which is slightly lower than the cut-off score (i.e., 10) 
suggested for diagnosis of clinically meaningful generalized anxiety disorder symptoms. Finally, 
mean trait anger score was 16.0 (4.4), which is considered to be on the low end of the trait anger 
spectrum based on the normative mean scores for college-aged adult populations (Spielberger et 
al., 1988). In summary, the sample in the study had sufficient levels of high trait anxiety, as well 
as sensitivity to their anxiety symptoms, but without significant levels of any other negative 
mood symptoms (i.e., anger or depressive symptoms). 
Manipulation checks for exercise intensity and anxiety/panic induction 
 Heart Rate (HR) and Rating of Perceived Exertion (RPE) during yoga and stretching 
protocols. A 2 × 3 (i.e., condition: yoga, control; × assessment time point during session: 10th 
min, 20th min, 30th min) ANOVA indicated no statistically significant interaction on HR, 
indicating that HR did not change in a differential manner across the 3 time points per condition. 
However, there was a significant main effect of condition on HR [F(1,16)=5.85, ηp2=.27, p<.05]. 
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The mean HR was 90 (SD=19.3) bpm during the yoga session and 78 (SD=14.9) bpm during the 
control session. Peak RPE values reported for yoga and control session were compared using 
paired samples t-tests. The results indicated a statistically significant difference between the 2 
conditions [t(17)=5.18,  p<.001]. Mean RPE was 12 (SD=1.8) for the yoga session and 9.8 
(SD=2.6) for the control session. Collectively, these HR and RPE values suggest that participants 
were working at a light-to-moderate intensity during the yoga condition and at a very light 
intensity during the control condition.  Accordingly, the yoga session selected for the study did 
not fully reach the initially targeted intensity level (i.e., moderate) for this intervention based on 
RPE and HR combined; however, it did approach moderate intensity based only on the RPE 
value. 
 FECO2 during CO2-inhalation task. The average values for FECO2 ranged between 
7.95% and 7.99% across all time points in both conditions. This was expected considering that 
the air mixture consisted of 7.5% CO2. The 2 × 3 (i.e., condition: yoga, control; assessment time 
point: T1, T2, T3) ANOVA indicated no significant interaction or main effects on FECO2 (p>.05 
for all). Accordingly, there is evidence that all participants inhaled the air mixture with the 
increased CO2 concentration without holding their breath, or air leaks from the mouthpiece or the 
gas collection bag. Furthermore, the lack of interaction or main effects indicates that this was 
achieved at all assessment time points and in both conditions. 
Baseline session: Reliability of CO2-inhalation task as anxiogenic/panicogenic 
 The mean scores (SD) on the self-reported measures from pre- to post-inhalation task 
during the two sessions at baseline are provided in Table 2.  There was a significant interaction 
between assessment time point (1st vs 2nd inhalation task) and exposure (i.e., pre- to post-
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inhalation task) on the API (F(1,17)=7.76, ηp²=.31, p<.05) and the SAI (F(1,17)=7.94, ηp²=.32 , 
p<.05). This indicates that the change (i.e., increase) in scores from pre- to post-exposure showed 
differential patterns at T1 vs T2 assessment points.  Specifically, the increase in API scores from 
pre- to post-exposure was smaller for T2 as the pre-exposure was slightly higher (i.e., from 1.39 
to 8.83 and 3.28 to 8.61 at T1 and T2, respectively). Similarly for the SAI, the increase from pre- 
to post-exposure was smaller at T2 (i.e., 33.78 to 46.61 and 39.78 to 43.44 at T1 and T2, 
respectively). . However, there were no such interactions on the VAS-A (F(1.17)=.44, ηp²=.03, 
p>.05) or the SAS (F(1,17)=.026, ηp²=.00, p>.05).  This indicates that the change in scores from 
pre- to post-exposure did not vary across the levels of assessment time points  
 There was a significant main effect of exposure on the API (F(1,1)=52.86, ηp²=.76, 
p<.001), SAI (F(1,1)=20.06, ηp²=.54,  p<.001), and the VAS-A (F(1,1)=13.37, ηp²=.44, p<.05). 
These collectively indicate that participants reported significantly elevated physical and 
psychological symptoms of panic and anxiety from pre- to post-exposure independent of 
assessment time points. This further suggests a lack of habituation effect to the inhalation task 
over time. On the other hand, there was no significant main effect of assessment time point for 
any of the scales (p>.05), indicating a lack of significant difference in scores between the 2 time 
points. There further was no significant main effect of exposure for the SAS (p>.05), indicating 
that the inhalation task did not have any statistically significant effect on the anger scores 
independent of assessment time points. Specifically, the state anger scores were very close to 15 
(i.e., lowest score possible on the SAS) at T1, and remained so all throughout the baseline 
session (i.e., pre- and post-exposure at both assessment time points).   
Primary Outcomes: Hypothesis 1 (Anxiety and panic symptoms) 
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When the phase of the menstrual cycle (i.e., luteal vs. non-luteal phase) was entered as a 
covariate factor into all the analyses, the results for the final ANCOVA models did not 
significantly differ from those of the ANOVA models. Accordingly, this variable was not 
included in the final models and only the results for the ANOVAs are reported in the subsequent 
sections.   
 The mean scores (SD) for the API, SAI, VAS-A and the SAS before and after CO2 
inhalation at each time point for both experimental conditions (i.e., yoga and control) are 
presented in Table 3. The results of the 2 × 3 ×	 2 (condition × assessment time point × exposure) 
ANOVA models are presented in Table 5. 
Acute Panic Inventory (API). There was no significant 3-way interaction between condition (i.e., 
yoga, control), assessment time point (i.e., T1, T2, T3) and exposure (i.e., pre- vs post- inhalation 
task) on API scores (p>.05). This lack of interaction indicates that participants’ responses to the 
inhalation task did not differ across assessment time points for the 2 conditions. Similarly, none 
of the 2-way interactions or main effects of condition or time point was statistically significant 
(p>.05), indicating that the exposure effect was independent of condition and assessment time 
point. There was a statistically significant main effect of exposure (p<.001), indicating that the 
CO2-inhalation task reliably induced symptoms of panic independent of condition and 
assessment time point (see Table 3). 
State Anxiety Inventory (SAI). Based on the repeated measures ANOVA, there was no significant 
3-way interaction between condition (i.e., yoga, control), assessment time point (i.e., T1, T2, T3) 
and exposure (i.e., pre- vs post- inhalation task) on SAI scores (p>.05). This again indicates that 
the anxiogenic response to the CO2-inhalation task did not differ across assessment time points 
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between the conditions. Specifically, the mean SAI scores increased from pre- to post-exposure 
at all assessment time points in both conditions. Similarly, there were no statistically significant 
2-way interactions (see Table 3). Finally, the main effect of condition was not statistically 
significant (p>.05), and this indicates that the condition did not have an effect on the change in 
scores across time points. However, there was a significant main effect of both assessment time 
point and exposure on the SAI scores (p<.001).This indicates that the scores increased from pre- 
to post-exposure independent of condition or assessment time points. Similarly, a significant 
main effect of time point indicates that the scores, collapsed over exposure and condition, were 
significantly different at each assessment point (i.e., 32.25, 27.03 and 30.50 for T1, T2, and T3, 
respectively). . 
Visual Analog Scale-Anxiety (VAS-A). Results of the repeated measures ANOVA indicated no 
statistically significant 3-way interaction between condition (i.e., yoga, control), assessment time 
point (i.e., T1, T2, T3) and exposure (i.e., pre- and post-inhalation task) (p>.05). This again 
indicates that the anxiogenic response (i.e., pre- to post-exposure) to the CO2-inhalation task did 
not differ across assessment time points between the conditions. Specifically, the mean VAS-A 
scores increased from pre- to post-exposure at all assessment time points in both conditions. 
However, the 2-way interaction between assessment time point and exposure was significant 
(p<.05), indicating that the exposure effect varied across assessment time points. Specifically, the 
change from pre- to post-exposure slightly increased from T1 to T3 (i.e., Δ values of ~15, ~17 
and ~21 for T1, T2 and T3, respectively). Furthermore, the main effects of assessment time point 
and exposure were both statistically significant at p<.001 (See Table 5). Collectively, these 
indicate that the inhalation task reliably induced symptoms of generalized anxiety from pre- to 
post-exposure based on the VAS-A, independent of condition (i.e., yoga or control). The lack of 
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main effect of condition (i.e., p>.05) indicates that this effect was independent of condition such 
that, in both conditions the pre-exposure scores at T2 and T3 were significantly lower than that 
of  T1 (see Table 3).  
Secondary Outcomes: Hypothesis 2 (anger) 
State Anger Scale (SAS). Results of the repeated measures ANOVA indicated no significant 
interaction between condition (i.e., yoga, control), assessment time point (i.e., T1, T2, T3) and 
exposure (p>.05). This indicates that the change in SAS scores did not differ significantly across 
assessment time points or conditions. Similarly, none of the 2-way interactions or main effects 
were statistically significant (p>.05). Main effect of assessment time point approached statistical 
significance (p=.06) (See Table 5), indicating that there was a trend toward a differential pattern 
of change in anger scores in response to the exposure independent of condition and exposure 
(i.e., pre- and post-exposure scores) (See Table 2). Specifically, when collapsed over exposure 
and across conditions, there was a slight decrease from T1 to T3 in the mean scores (i.e., 15.49, 
15.18, 15.17 for T1, T2, and T3, respectively).  However, there was a large floor effect (i.e. mean 
(SD) scores of 15.22 (0.56) and 15.33 (0.46) for yoga and control conditions, respectively). In 
combination with the consistent changes in anxiety and panic symptom scores from pre- to post-
inhalation tasks, these results collectively provide evidence for the construct validity for our 
anxiety induction model (i.e., 5 minutes of 7.5% CO2-inhalation) in this study. 
Secondary Outcomes: Hypothesis 3 (Respiratory measures) 
The mean (SD) peak values for RR, Vt and VE at each assessment time point during the 
final (i.e., 5th) minute of exposure for both experimental conditions (i.e., yoga and control) are 
presented in Table 4. The results of the ANOVA did not differ significantly based on method of 
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data analysis (i.e., peak values during minute 5 of inhalation period vs. 30-second averages over 
the entire inhalation period), and both versions of the data analysis is presented in text and 
Tables 6 and 7. This lack of difference suggests that there were no differential pattern of 
responses to the CO2-inhalation task based on the method of data analysis. Overall, RR and VE 
significantly increased over the course of the 5 minutes of exposure (based on the results of the 2 
x 3 x 10 ANOVA: see Table 6); however, this did not differ significantly across the 3 assessment 
time points (i.e., T1, T2, T3) or the 2 conditions (i.e., yoga or control). Finally, there was a 
significant main effect of exposure (i.e., 10 30-second intervals) on all 3 outcomes based on the 2 
x 3 10 ANOVA; but not based on the 2 x 3 ANOVA. This would make sense given the former 
analysis includes this as an additional factor and thus provides a more comprehensive profile for 
the respiratory response to the inhalation task. Accordingly, this method of analysis was the 
focus in the following sections on the description and discussion of these results. 
 Peak respiratory rate (RR). Results of the repeated measures ANOVA indicated no 
significant interaction between condition (i.e., yoga, control) and assessment time point (i.e., T1, 
T2, T3) [F(2,32)=1.42, ηp2=.08, p>.05]. This suggests that RR at each time point did not 
significantly differ across conditions. There was a significant main effect of assessment time 
point [F(2,32)=3.40, ηp2=0.68, p<.05], but not a significant main effect of condition (p>.05). 
This indicates that the RR differed across the 3 time points (i.e., T1, T2, T3), independent of the 
condition (See Table 4). Specifically, when collapsed over conditions, there was a very slight 
decrease in RR over time. However, this was no longer significant when all 5 minutes of 
exposure were included in the repeated measures ANOVA (See Table 6). 
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 Peak tidal Volume (Vt). Results of the repeated measures ANOVA indicated no 
significant interaction between condition (i.e., yoga, control) and assessment time point (i.e., T1, 
T2, T3) [F(2,342)=.99, ηp2 =.06, p>.05]. This suggests that Vt at each time point did not differ 
significantly across conditions. Specifically, the values ranged from 1.74 to 1.77 in the yoga 
condition and from 1.72 to 1.76 in the control condition. There further were no significant main 
effects of condition or assessment time point (p.>05 for both). Specifically, the mean values 
collapsed over time were 1.76 lt and 1.74 lt for yoga and control conditions, respectively. 
 Peak ventilation (VE). Results of the repeated measures ANOVA indicated no significant 
interaction between condition (i.e., yoga, control) and assessment time point (i.e., T1, T2, T3) 
[F(2,32)=.11, ηp2=.01, p>.05]. This indicates that peak ventilation did not differ across the 2 
conditions or the 3 assessment time points. However, the mean values collapsed across the 3 
assessment time points were not significantly different between the 2 conditions (i.e., ~47lt/min), 
as indicated by the statistically non-significant main effect of condition (p>.05). On the other 
hand, main effect of assessment time point approached significance [F(2,32)=3.12, ηp2=6.23, 
p=.06]. This suggests that there was a change (i.e., slight increase) in VE at each assessment time 
point, which was independent of condition. However, this was no longer significant when all 5 
minutes of exposure were included in the repeated measures ANOVA (See Table 6). 
Other outcome measures 
 Minute-by-minute VAS-A. VAS-A assessments taken at the end of each minute of the 
CO2-inhalation were analyzed in a 2 × 3 × 5 (i.e., condition; yoga, control; × assessment time 
point: T1, T2, T3; × minute of exposure: 1st through 5th) ANOVA. The results of the ANOVA 
indicated no significant 3-way or 2-way interactions (p>.05). This suggests that the change in 
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VAS-A over the course of exposure did not differ across the assessment points or the 2 
conditions. However, there was a significant main effect of minute of exposure, such that the 
scores significantly increased over the course of the 5 minutes, and this was independent of 
condition or assessment time points. This change in scores over the course of the 5 minutes of 
exposure is presented in Figure 2.  
 Carbon dioxide production (VCO2). The 2 × 3 (i.e., condition ×	 assessment time point) 
ANOVA results indicated that there were no statistically significant interactions or main effects 
of condition or assessment time point (p>.05) on the CO2 production. This indicates that the CO2 
production was consistent across conditions and assessment time points. The mean VCO2 values 
(SD) at T1, T2 and T3 were 3.02 (.80), 2.58 (1.81) and 3.04 (.87) for the yoga condition and 2.93 
(.75), 2.92 (.78) and 2.99 (.78) for the control condition.  
 Mindfulness. Mean scores on the state mindfulness scale (i.e., MAAS-S) immediately 
after yoga (M=1.07(SD=1.04)) and control (M=1.17 (SD=.80)) did not significantly differ 
between conditions based on the results of the paired samples t-test (T(17)=-.50, p>.05). These 
scores suggest that the participants did not feel any more mindful after the yoga session when 
compared to after the stretching control condition. The mean score on the trait mindfulness (i.e., 
MAAS-T) was 3.78 (.9), which is consistent with what has been reported in this population (i.e., 
M= 3.83 (.7) (Brown and Ryan, 2003). In addition, when the mean MAAS-T scores were entered 
into the model as a covariate, it did not have a statistically significant effect on the results of the 
final ANOVA models for the self-reported outcome measures (i.e., API, SAI, SAS and VAS-A). 
This indicates that the response to the inhalation task was consistent across all time points and 
both conditions independent of the participants’ self-reported trait mindfulness scores. However, 
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it is possible that the small variance in the scores might have influenced this lack of statistical 
significance. 
 In summary, there are 3 important main outcomes based on the results of this study. First, 
there was no differential effect of condition on the anxiolytic response. Specifically, the yoga 
intervention did not induce a larger attenuation in the anxiogenic response when compared to the 
control condition. This finding does not provide support for the 1st hypothesis and is further not 
in accordance with previously published similar studies. Second, there was an attenuation in the 
cognitive symptoms of anxiety, based on the change in the SAI and VAS-A scores, across the 
assessment time points when collapsed over condition and exposure. On the other hand, the 
respiratory outcomes did not parallel the self-reported outcomes, and this refutes the secondary 
hypothesis regarding the physiological/respiratory outcomes. That only the cognitions of general 
anxiety, but not panic or physiology of anxiety, attenuate over time indicates an overall effect of 
general physical activity and this is in line with previous studies. Finally, the inhalation task used 
in the present study was anxiety/panic-specific, based on the consistent, reliable change in both 
the self-reported and respiratory measures of anxiety and panic, but not anger, from pre- to post-
exposure that was independent of condition and assessment time point. While this refutes the 
secondary hypothesis regarding acute anger, it does provide preliminary evidence for the 
construct validity of the model.  
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CHAPTER 5: DISCUSSION 
Overview of the results  
The purpose of this study was to investigate the acute anxiolytic effects of a vinyasa-style 
yoga session in response to an anxiogenic, 5-minute 7.5% CO2-air mixture exposure in women 
with self-reported trait anxiety sensitivity (i.e., a score of ≥25 on the ASI). Overall, our results 
from the 3-way interactions provide no evidence for a differential change in anxiety or panic 
response between acute, light-to-moderate intensity yoga and an active control session involving 
light stretching for attenuating the response to a biological anxiogenic stimulus (i.e., CO2-
inhalation task) (p>.05). Similarly, respiratory response to the inhalation task did not 
significantly differ across any of the assessment time points between the 2 conditions. However, 
when collapsed over exposure and condition, there was a reduction in SAI and the VAS-A scores 
that sustained over time (i.e., a main effect of assessment time point). There were no such effects 
for the API scores (i.e., physical panic symptoms), however. Collectively, these results point to a 
reduction in cognitive aspects of anxiety irrespective of the physiological aspects of anxiety or 
panic in our sample in response to the CO2-inhalation task after both conditions. This potentially 
indicates an effect of general physical activity, passage of time or time-out effect. However, 
given the lack of changes in panic and respiratory outcomes, it is unlikely to be a passage of time 
or time-out effect. That is, we would have expected to observe the same pattern of reduction 
across all outcome measures for a passage-of-time effect. Therefore, the specificity of the 
cognitive anxiety changes points to a more anxiety-specific effect for both yoga and stretching. 
Finally, there was a consistent, reliable increase in both physical panic and anxiety symptoms 
from pre- to post-exposure (i.e., exposure main effect), but not anger, in response to the 
anxiogenic stimulus at all assessment time points (p<.05), providing evidence to the construct 
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validity of the protocol. There were no significant changes in results for any of data analyses 
after controlling for phase of menstrual cycle (i.e., luteal vs non-luteal), and trait mindfulness 
scores. 
Primary hypothesis 
Our primary hypothesis that yoga would attenuate the self-reported anxiety response 
more so than the control condition was not supported, based on the lack of differences in self-
reported outcome measures between the 2 conditions (p>.05). Our results suggest that in 
comparison to the control condition, participants did not experience any statistically significant 
attenuation in self-reported panic or anxiety after the yoga intervention in response to the CO2-
inhalation (p>.05). In addition, the increases in anxiety symptoms in response to the inhalation 
task were statistically significant at all time points, regardless of the condition (p<.05). 
Accordingly, the proposed hypotheses were only partially supported in that, participants 
experienced significant increases in physical panic and generalized anxiety symptoms in 
response to the inhalation task at all time points based on the scores on the API, SAI and VAS-A 
from pre- to post-exposure, as well as based on the minute-by-minute VAS-A assessments 
during the exposure, but this was not influenced by yoga. Findings on the VAS-A indicate an 
overall effect of physical activity on the cognitions of generalized anxiety. When collapsed over 
exposure and condition, the mean scores for each assessment time point were 23.32 (SD=14.91), 
15.82 (SD=12.22) and 17.69 (SD=13.66), respectively. These translate to ESs (i.e., Cohen’s d) of 
0.55 and 0.39 from T1 to T2 and T1 to T3, respectively. These ESs would be considered of 
medium in magnitude are larger than what has been reported by previous meta-analyses (e.g., 
Ensari et al., 2015; Petruzzello et al., 1991) on the efficacy of acute exercise for reducing anxiety 
symptoms (e.g., Cohen’s d=.24 and Hedge’s g=.16, respectively). When collapsed over 
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condition and exposure, there was attenuation in the increase on SAI scores and this is discordant 
with those of others. For example, in the study by Broman-Fulks et al., (2015), SAI scores were 
the only scores (among other anxiety measures such as the ASI) that did not change after the 
resistance training session. The authors suggested that this might perhaps be due to a delayed 
anxiolytic response, which they could not capture (as they did not include a delayed response 
assessment). However, we addressed this in our study by assessing response at 1 hour post-
intervention and provide preliminary evidence for an attenuation effect that is independent of 
condition and also irrespective of physical and physiological symptoms of anxiety. Given the 
lack of differential pattern of change in scores between conditions, it might be possible to 
suggest that the slightly anxiogenic effect of yoga might pertain to the stretching and/or 
meditation components, as those were also included in the control protocol. Accordingly, these 
findings confirm and provide an update on the previously reported tension-relieving effects of 
muscle stretching relaxation techniques in moderately anxious samples (e.g., Carlson et al., 
1990; Bernstein & Borkovec, 1973). 
Secondary hypothesis 
Our secondary hypothesis regarding the anger response was not supported. There was no 
evidence for a differential pattern of change in scores from pre- to post-exposure at any 
assessment time points between the conditions (i.e., non-significant 3-way or 2-way 
interactions). Furthermore, there was a large floor effect (i.e., a score of ~15 at all points) in the 
anger response where, the scores remained low from pre- to post-exposure and throughout the 
assessment time points in both sessions. One rationale for including an anger measure in this 
study was to account for the influence of potential differences in anger levels between 
participants on the primary outcome measures. Previous researchers have reported significant 
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associations between symptoms of anger and symptoms of anxiety and panic (e.g., Moscovitch et 
al., 2007). To our knowledge, this is the first study to account for this potential confounding 
influence and we report that anger does not appear to be prevalent in individuals with heightened 
AS or influence the anxiogenic or panicogenic response to the CO2-inhalation task. It might be 
possible that this comorbidity previously reported by others is more likely in those with a 
clinically diagnosed condition (e.g., PD, OCD). Anger was not affected by the CO2-exposure in 
our sample; and this makes the model more anxiety-specific in interpretation. Collectively, they 
provide construct validity of the CO2-inhalation protocol as a method for inducing physical panic 
and cognitive symptoms of generalized anxiety. 
There was partial evidence for the secondary hypothesis regarding the respiratory 
outcomes. Specifically, there were no 3-way interactions, indicating a lack of differential effect 
between yoga and stretching conditions for attenuation of respiratory rate or ventilation or 
increasing tidal volume. However, there was a significant main effect of exposure where the rate 
of respiration and ventilation increased over the course of the inhalation task (p<.05). These 
effects were consistent across time points and conditions, as indicated by the lack of 2-way 
interaction or main effects of condition or assessment time point (p>.05). This pattern of increase 
indicates that physiological changes do indeed parallel the self-reported panic symptoms in 
response to this experimental anxiogenic stimulus. However, they do not parallel the self-
reported cognitive symptoms of anxiety. Collectively, these findings suggest that the acute 
cognitive improvements that are seen after a bout of yoga or stretching activities might be 
independent of the possibly inherent and centrally-mediated physiological responses to the CO2-
inhalation task. Findings of others who have investigated the respiratory response to 7.5% or 
other similar concentrations of CO2-inhalation tasks (e.g., Shafer, 1958; Zandbergen et al., 1991) 
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and our results somewhat agree. For example, one such study divided a group of individuals into 
“high” vs “low” ventilators to the 7.5% CO2-inhalation task based on the severity of their panic 
symptomology (Shafer, 1958). The results indicated that within the first 5 minutes of the 
inhalation task, high ventilators exhibited much greater RR but lower Vt when compared to low 
ventilators. The range of RR in the high ventilators in this study was 20-30 (means not reported), 
whereas the mean RR in our study ranged between 28 and 29. Another similar study reported a 
mean RR of 23 and Vt of ~1.6lt for “responders” (i.e., those who respond to the CO2-inhalation 
with significantly increased ventilatory response) during the first 5 minutes of a 10-minute 
inhalation of 7% CO2-inhalation (Papp et al., 1997). This reported Vt value is closer what is 
reported in the current study (i.e., 1.6-1.7lt), and accordingly provides further confirmatory 
evidence for the respiratory response that is typically observed in sensitive individuals (i.e., 
“responders” or “high ventilators). Another study compared ventilatory response to the Reading 
rebreathing method (a similar type of CO2-inhalation protocol involving the participant breathing 
the same gas mixture from a gas collection bag) in healthy control participants vs patients with 
PD (Zandbergen et al., 1991). Their results indicated that the group with PD responded with 
greater VE (Range: 20-40 lt/min; means not reported) in comparison to the healthy control group 
(Range: 10-20lt/min, means not reported). The mean VE values we observed in our study had a 
range of 45.76-47.76 lt/min. The observed differences might have been due to factors such as 
sample characteristics, and the differences in the breathing protocols used. Overall, our findings 
build upon these by providing a comprehensive profile of both cognitions and physiology of 
anxiety in response to the CO2-inhalation task before and after a bout of physical activity. 
Accordingly, it appears that the cognitive versus physiological responses to the CO2-inhalation 
protocol might be independent of each other in individuals with heightened anxiety sensitivity. 
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 This study has several novel features that address the limitations in the existing literature 
on experimental models of anxiety using the CO2-inhalation paradigm and acute exercise. These 
differences can be categorized as those relative to the inhalation task, physical activity 
intervention and sample. First, the previous 5 studies published on this topic have used a single 
or double inhalation of 35% CO2-air mixture, which is a panic induction protocol, not an 
anxiety-specific protocol. On the contrary, our goal was to induce symptoms of generalized 
anxiety symptoms and therefore we used a 7.5% CO2 concentration and exposed our participants 
for 5 minutes. Based on the consistent increase in symptoms of anxiety (in addition to panic), but 
not anger, we provide evidence that this is a feasible model to study states of generalized anxiety 
and its related cognitions and physiology under experimental conditions. We further provide 
construct validity for this novel protocol given the lack of any significant changes in anger scores 
from pre- to post-exposure. To our knowledge, this is the first study to administer this specific 
protocol in an attempt to induce a more generalized anxiety state in participants and assess this 
state by administering both anxiety and panic measures, as well as anger measure, to discern the 
these different constructs that are often reported to overlap.  
 Similarly, we assessed change in response over time by administering the inhalation task 
both before and after the intervention and furthermore, by administering the mood questionnaires 
before, during and after each inhalation. On the contrary, previous studies have administered the 
CO2-inhalation challenge only after the exercise intervention, which is a limitation of the 
previous studies as this prevents them from being able to compare the post-exercise response to a 
reference point (i.e., the T1 assessment) before exposure to any aspects of the study (e.g., 
intervention protocol, inhalation protocol). This is important to consider, especially given that 
the sessions were scheduled on different days, as there might be differences in physiological or 
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psychological measures between conditions at baseline, due to reasons unrelated to the 
experimental and study design (e.g., personal issues, hormonal fluctuations, sickness, outside 
stressors). Next, we assessed both immediate and delayed (i.e., 1-hour post-intervention) 
response, in an attempt to investigate the sustainability of the response over time. This makes the 
current study design stronger and allows for assessment of effect longevity. Similarly, we 
assessed self-reported anxiety response throughout the inhalation task, which allowed for 
comparisons between self-reported and physiological changes (e.g., ventilation, respiratory 
frequency) over the course of the inhalation. Assessment of symptoms during inhalation has been 
recommended by previous researchers (e.g., Bailey et al., 2005) for capturing a more 
comprehensive profile of the continuous fluctuations in the anxiogenic response. Given the lack 
of condition main effects in our study, however, it is difficult to infer whether the respiratory 
response profile might have followed a differential pattern with a higher-intensity physical 
activity intervention. For example, maybe an aerobic-type physical activity protocol that 
significantly increases heart rate might have resulted in more substantial changes in respiratory 
rate, ventilation and tidal volume afterwards. Since there were no statistically significant 3-way 
interactions; however, we are unable to comment on whether a session of yoga can help attenuate 
the anxiety response more effectively than a light stretching protocol over time.  
 Next, there were some important differences in the physical activity paradigm between 
this and previous studies. That is, our physical activity intervention was a light-to-moderate 
intensity yoga condition, whereas previous studies have used walking, cycling and resistance 
training as modality, and higher intensities than ours, in their designs. Indeed, previous studies  
using aerobic-type interventions such as cycling and walking in their designs (e.g., Broman-
Fulks et al., 2015; Esquivel et al., 2008, 2012; Smits et al., 2009) have reported larger attenuation 
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in response to the CO2-inhalation challenge after the exercise bout in comparison to the control 
condition. Consequently, this might have contributed to the smaller ESs we observed in this 
study, in comparison to some of the ESs reported in previous studies (e.g., ηp²=.52 for AS and 
ηp²=.17 for API, reported by Broman-Fulks et al., 2015). We further did not have a true, no-
exercise control condition but instead, a light stretching control condition. In this regard, our 
design is similar to those of Esquivel et al. (2002, 2008, 2012). For example, one of those studies 
recruited a sample with a clinical diagnosis of panic disorder and reported significantly 
attenuated response to the CO2-inhalation challenge after moderate-to-hard intensity cycling, but 
not after very light-intensity cycling (e.g., Esquivel et al., 2008). Accordingly, it is possible that 
the yoga protocol in the current study might have failed to induce greater benefits than the 
control stretching activity due to its lower intensity. Both meta-analytic (e.g., Ensari et al., 2015) 
and experimental studies of similar type (e.g., Broman-Fulks et al., 2015; Esquivel et al., 2008) 
point to the greater effects observed after higher-intensity exercise. A replication of our study 
using a higher intensity yoga protocol as the physical activity intervention to see if this can 
improve the attenuation of the anxiogenic response would be beneficial and subsequently allow 
for generation of practical recommendations for the target population (e.g., those with clinically 
meaningful levels of anxiety and panic symptoms and sensitivity). 
 Finally, our sample was a relatively unique one that consisted of otherwise healthy 
women with high sensitivity toward their physical anxiety and panic symptoms. Specifically, we 
recruited a sample with a mean ASI score of 32.2 (SD=6), which is approximately 1 SD above 
the threshold score of 25 that is indicated to suggest clinically meaningful AS (Taylor et al., 
2007). Previous studies of acute exercise and CO2-inhalation have included samples with lower 
mean ASI scores (e.g., Broman-Fulks et al., 2015; Smits et al., 2009). On the other hand, we 
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excluded those with current or past diagnosis of anxiety or panic disorder, and those who were 
using any psychotropic medication at the time of the study. Accordingly, this might help partially 
explain the discrepancy between our results and theirs. That is, it is possible that the anxiogenic 
response to the CO2-inhalation task is not attenuated significantly in individuals with clinically 
meaningful levels of trait AS. This argument finds further support from previous literature 
suggesting that the panicogenic response to the CO2-inhalation task is centrally-mediated, 
implicating the amygdala (Argyropoulos et al., 2002; Gorman et al., 2001), and that the 
physiological change (i.e., increased ventilation) is genetically determined (Kawakami et al., 
1982) and involves the chemoreceptors (e.g., Zandbergen et al., 1991). If this is indeed true, then 
such an acute intervention like ours cannot realistically be expected to attenuate this response 
and would require the assessment of a longer intervention (e.g., 12 weeks). Based on the present 
findings, this theory of a centrally-mediated, genetically determined pattern might also be true 
for generalized anxiety. Accordingly, it might be possible to suggest that individuals with 
heightened sensitivity have a lower threshold for stimuli such as air mixtures with increased CO2 
concentration and based on the previously theories (Zandbergen et al., 1991), that this might 
under the influence of the chemoreceptors (i.e., “impaired chemoreceptor sensitivity”). 
Combined with the results of the self-reported data, it might be possible to suggest that the acute 
attenuation in anxiogenesis is independent of the physiological symptoms of anxiety. Obviously, 
longitudinal studies are required to clarify whether physiological symptoms would follow 
cognitive symptoms.  
The inclusion of only women in the present sample is an important aspect of the study for 
2 main reasons that deserve further elaboration. First, anxiety disorders are significantly more 
prevalent (i.e., ~2:1 prevalence) and debilitating (i.e., less likely to receive treatment and 
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associated with more comorbidities) in women than in men. Therefore, we acknowledge the 
importance of focusing research efforts to possibly find alternative approaches for targeting these 
negative symptoms, which may or may not be unique to this demographic, by designing a study 
that specifically targets women. Second, women are reportedly underrepresented in biomedical 
research and only recently have there been more deliberate efforts to include women participants 
in studies (Rieker & Bird, 2005). Frequently, this exclusion has been justified by the goal to 
provide a homogenous sample (i.e., therefore fewer potential between-subjects differences at 
baseline) and also the difficulties of adjusting for the hormonal and other related physiological 
fluctuations (e.g., those that occur as a part of the menstrual cycle) (e.g., Killien et al., 2004; Kim 
et al., 2000). This gap in the literature is particularly essential to consider for the purposes of this 
study. There is preliminary evidence that use of hormone-based contraception can alter the 
estrogen-progesterone fluctuations and consequently, can disable the anxiety-buffering effect of 
estrogen during the non-luteal phase. For example, women low on estrogen levels have been 
reported to have an impaired ability to attenuate their startle response when faced with a 
panicogenic (e.g., Glover et al., 2015). When faced with the CO2-inhalation task, then, these 
women would be expected to show greater sensitivity than those who are not. Indeed, this luteal 
drop in estrogen levels has been reported by others to influence the panicogenic and/or 
anxiogenic response to the CO2-inhalation task (e.g., Niilni et al., 1999; Perna et al., 1995). 
Interestingly, our results indicated no such effect, as the results for the final ANOVA model were 
not statistically different than the results of the ANCOVA with this variable included as a 
covariate factor. This discrepancy between our results and others might have been due to the 
differences in the sample characteristics. For example, another similar study compared the 
anxiogenic response to 5% and 7% CO2-inhalation challenge in separate groups of women with 
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major depressive disorder (MDD), pre-menstrual dysphoric disorder (PMDD), panic disorder 
(PD) or those without (i.e., healthy control) (Gorman et al., 2001). The results of this study 
indicated that the elevation in anxiogenesis was comparable between those with PD and those 
with PMDD and furthermore, that these 2 groups responded with much greater anxiety than the 
other 2 groups (i.e., healthy control and those with MDD). However, the physiological response 
(i.e., change in respiratory rate and ventilation) was comparable across all groups. The authors 
concluded that these findings collectively point toward the existence of a central fear mechanism 
that involves an inherent conditioning to anxiogenic stimuli in some individuals. Our findings 
would seem to be in accordance with those of Gorman et al., (2001) and therefore their proposed 
mechanism could also apply to our sample. That is, it is possible that we have selected such a 
group of individuals (i.e., those with significant levels of AS) and therefore this hypothesized 
inherent, central fear mechanism overrides any possible anxiety-attenuating effect of the acute 
exercise bout in our participants. Taking into account our findings, as well as those 
aforementioned, it is clear that further research with a focus on samples consisting of women are 
needed to clarify these points. 
Limitations and future directions 
 This study is not without limitations. First, the sample size was relatively small. 
Subsequently, the effect sizes (i.e., ηp²) for interaction and main effects were in the small-to-
moderate range in our study, whereas others before us have reported larger ESs (e.g., ηp²= .17 
for a 3 X 3 ANOVA of API scores in the study by Broman-Fulks et al. (2015). Therefore, it is 
possible that statistically significant results might be observed with a larger sample size. Next, 
this study did not have a true, no-exercise control condition and therefore it is not possible to 
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conclude whether acute yoga is more efficacious for anxiety attenuation than seated quiet rest or 
an alternate no-exercise activity (e.g., reading). It is possible that the stretching protocol in the 
present study mimicked the yoga protocol too closely. In other words, the control condition was 
might have been overbuilt and therefore was too “active”. To circumnavigate this problem in the 
future, having a meditation session instead might be another alternative as a control condition. 
This would then prevent the problem of a potentially “overbuilt” control condition that is too 
similar to the active condition and furthermore, control for the effect of the meditation 
component that is already inherent in the yoga condition. Similarly, both the yoga and stretching 
were conducted on a 1-on-1 basis; and it is possible that this made some of the participants feel 
self-conscious while doing the poses. Subsequently, the yoga session might not have been as 
anxiolytic for such participants as intended. Similarly, we recruited participants who were “yoga-
naïve”. Our selection criterion was doing yoga <2/week and most participants in our sample 
reported not doing any yoga at all in past 6 months at least. Accordingly, this lack of familiarity 
with the poses might then have led to a state of cognitive activation where, the participants were 
paying so much attention to trying to execute the poses that any possible anxiolytic effects were 
greatly reduced. There is some preliminary, indirect indication of this based on the relatively low 
MAAS-S scores reported after both conditions. It is possible that the mood-improving benefits of 
yoga start to occur after some familiarization with the practice. In this regard, conducting 
longitudinal studies to assess such potential benefits might help clarify this point. Alternatively, 
comparing these effects in those who are regular yoga-practitioners versus those who are not 
(i.e., “Yoga-naïve”) would help elucidate familiarity is indeed an influential factor. Such 
familiarization would allow the individuals to flow through the poses at a faster pace and 
potentially achieve a higher heart rate. This would further help address whether it is the intensity 
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of the yoga that drives the anxiolytic effect. Furthermore, we did not control for PA levels at 
baseline and our sample consisted of physically active individuals who met the PA Guidelines 
(USDHHS, 2008). It is possible that replication of the current design with a sample of 
individuals who are sedentary might yield a different set of results and accordingly, comparison 
of those who are physically active versus those who are not would help clarify this question. 
Finally, there was a mix of participants in our sample who were using hormone-based 
contraceptive methods and those who were not (i.e., 11:7). As discussed above, this might have 
altered the natural ability of the body to regulate the possible anxiolytic effect of the yoga 
intervention in response to the CO2-inhalation task in some of the participants due to their 
relatively lower estrogen levels. In this regard, recruiting a sample of women who are not using a 
hormone-based birth control method might better clarify whether the pattern of the anxiogenic 
response differs as a covariate of the menstrual cycle phase (e.g., an expected direction of greater 
attenuation in response during non-luteal phase). Similarly, it should also be noted that the 
determination of the luteal vs non-luteal phase at the time of testing was approximate and was 
based on the self-reported 1st day of menstrual period. Luteal phase can last anywhere between 6 
and 14 days and accordingly; the categorization might have been slightly erroneous for some 
participants. Therefore, the results of the ANCOVA should be interpreted with caution. 
It appears that both vinyasa-style yoga and light stretching-type activity might induce 
effects of general physical activity for attenuating anxiogenesis and might be feasible approaches 
to counter the effects of a future anxiogenic or panicogenic stressor for an individual (e.g., an 
upcoming interview, getting on a flight). This practical suggestion is based on the condition-
independent attenuation in the generalized anxiety response over the course of the assessment 
time point (i.e., T1 through T3). These findings provide an update on and expand upon 
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previously reported beneficial effects of muscle relaxation techniques among individuals with 
self-reported anxiety (e.g., Carlson et al., 1990; Bernstein & Borkovec, 1973). The current results 
are further in line with previous research on the anxiolytic effects of physical activity (e.g., 
Ensari et al. 2015; Esquivel et al., 2012). Given the increasing popularity of yoga as an 
alternative treatment approach for a variety of health conditions and symptoms and as well the 
wide range of yoga styles commercially available, it is timely to investigate yoga as a physical 
activity modality in well-designed, rigorous experimental studies so as to delineate its true mood-
improving effects.  
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CHAPTER 6: CONCLUSIONS 
 In conclusion, there was no evidence for a differential pattern of change between an acute 
bout of vinyasa style yoga and a stretching control condition for attenuating the anxiety and 
panic symptoms in response to the 5-minutes of 7.5% CO2-inhalation task in women with high 
AS. However, there was an overall reduction in cognitive anxiety symptoms after both 
conditions, suggesting an overall effect of general physical activity for reducing cognitions of 
anxiety. Our results are partially in accordance with previous research in this area (e.g., Broman-
Fulks et al., 2015; Smits et al., 2009), and this might be due to the methodological differences 
between studies. First, all previous studies investigated symptoms of panic, not anxiety, and 
accordingly have used a single or double-inhalation of 35% CO2-air mixture (Broman-Fulks et 
al., 2015; Esquivel et al., 2002; 2009; 2012; Smits et al. 2009). Next, those studies did not assess 
change in scores (i.e., pre- to post-exposure). This is a more robust method for assessing change 
in response to an acute exercise stimulus, as it takes into account any potential fluctuations in 
pre-exposure scores across participants. Possible influence of the phase of menstrual cycle was 
also accounted for by including it as a covariate factor in the data analyses, and the results did 
not significantly change. Future studies should recruit larger samples and include a true, no-
exercise control condition to account for the passage of time. Investigation of higher-intensity 
yoga protocols for would also elucidate whether this would improve the attenuation response. 
This study provides the first evidence that 5 minutes of 7.5% CO2-inhalation task is a reliable 
method to induce symptoms of both panic and more generalized anxiety in sensitive individuals 
and that there does not seem to be a habituation response to these effects either acutely or over 
several (i.e., 3-4) weeks. Accordingly, this method can be used for studying models of anxiety 
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and panic under laboratory conditions as a valid method for experimental induction of such 
symptoms. 
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CHAPTER 7: TABLES AND FIGURES 
Table 1. Descriptive characteristics for the study sample (N=18). SD=Standard deviation.  
Variable Mean (SD) 
Age (years) 22.1 (5.0) 
Height (cm) 166.2 (4.9) 
Weight (kg) 64.9 (11.4) 
HADS-Anxiety 9.8 (4.7) 
HADS-Depression 5.2 (3.9) 
GADS-7  8.4 (4.8) 
Trait Anxiety 46.4 (10.3) 
Trait Anger 16.0 (4.4) 
ASI-3 score 24.9 (10.3) 
Trait Mindfulness 3.8 (.9) 
GLTEQ score 40.9 (21.2) 
Hormone-based 
contraceptive use (%) 
11 (61%) 
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Table 2. Mean scores (SD) on the self-report measures to the 1st and 2nd inhalation tasks 
during the baseline session. API=Acute Panic Inventory, SAI=State Anxiety Inventory, 
SAS=State Anger Scale, VAS-A=Visual Analog Anxiety Scale. 
 
Time point API SAI SAS VAS-A 
 Pre Post Pre Post Pre Post Pre Post 
1st inhalation 
task 
1.39 
(1.50) 
8.83 
(4.63) 
33.78 
(8.97) 
46.61 
(10.49) 
15.50 
(0.86) 
15.50 
91.04) 
26.39 
(18.29) 
40.89 
(21.33) 
         
2nd inhalation 
task 
3.28 
(2.49) 
8.61 
(3.74) 
39.78 
(9.00) 
43.44 
(11.45) 
15.33 
(0.77) 
15.39 
(0.70) 
24.83 
(17.01) 
36.83 
(24.05) 
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Table 3. Mean scores (SD) on the self-report measures to the 1st, 2nd and 3rd inhalation tasks 
during the experimental (i.e., yoga) and control (i.e., stretching) sessions. API=Acute Panic 
Inventory, SAI=State Anxiety Inventory, SAS=State Anger Scale, VAS-A=Visual Analog 
Anxiety Scale. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time point API SAI 
 Yoga Control Yoga Control 
 
Pre Post Pre Post Pre Post Pre Post 
1st inhalation 
task 
1.00 
(1.33) 
8.39 
(4.67) 
1.06 
(1.55) 
8.89 
(5.17) 
31.55 
(8.58) 
43.06 
(12.11) 
32.94 
(10.31) 
43.17 
(10.72) 
2nd inhalation 
task 
1.17 
(2.20) 
8.50 
(5.87) 
.72 
(1.41) 
6.89 
(2.87) 
26.83 
(6.04) 
39.67 
(12.00) 
27.22 
(8.82) 
40.06 
(10.94) 
3rd inhalation 
task 
.83 
(1.29) 
8.67 
(6.13) 
.67 
(.97) 
7.61 
(5.98) 
29.17 
(9.88) 
42.17 
(12.55) 
31.83 
(9.16) 
41.11 
(13.48) 
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(Table 3 cont.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time point VAS-A SAS 
 Yoga Control Yoga Control 
 Pre Post Pre Post Pre Post Pre Post 
1st inhalation 
task 
13.67 
(12.43) 
28.83 
(21.60) 
17.83 
(13.76) 
32.94 
(22.10) 
15.17 
(.71) 
15.39 
(.14) 
15.61 
(.45) 
15.78 
(.32) 
2nd 
inhalation 
task 
6.72 
(7.27) 
24.00 
(21.65) 
8.17 
(10.11) 
24.39 
(19.34) 
15.06 
(.06) 
15.11 
(.08) 
15.33 
(.33) 
15.22 
(.13) 
3rd inhalation 
task 
7.67 
(9.25) 
27.22 
(22.17) 
6.78 
(7.10) 
29.11 
(24.85) 
15.17 
(.17) 
15.06 
(.06) 
15.00 
(.00) 
15.44 
(.29) 
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Table 4. ANOVA results for the Acute Panic Inventory (API), State Anxiety Inventory 
(SAI), Visual Analog Anxiety Scale (VAS-A), and the State Anger Scale (SAS) scores. 
Condition (yoga, control), Time point (Baseline, immediately post yoga/control, 1 hour post 
yoga/control), exposure (pre- and post-inhalation task).   
API df F ηp² p 
Condition 1 1.49 .08  
Time point 2 1.31 .07  
Exposure 1 55.53 .77 <.001 
Condition*time point 2 1.27 .07  
Condition* Exposure 1 .88 .05  
Time point* Exposure 2 .64 .04  
Condition*time point* Exposure 2 1.25 .07  
SAI df F ηp² p 
Condition 1 .32 .02  
Time point 2 9.63 .36 <.001 
Exposure 1 40.08 .70 <.001 
Condition*time point 2 .52 .00  
Condition* Exposure 1 1.09 .06  
Time point*Exposure 2 .88 .05  
Condition*time point* Exposure 2 1.06 .06  
VAS-A  df  F ηp² p 
Condition 1 .94 .05  
Time point 2 14.31 .46 <.001 
Exposure 1 21.52 .56 <.001 
Condition*time point 2 1.84 .10  
Condition* Exposure 1 .06 .00  
Time point* Exposure 2 3.58 .17 <.05 
Condition*time point* Exposure 2 .35 .02  
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(Table 4 cont.) 
SAS df F ηp² p 
Condition 1 1.85 .10  
Time point 2 3.07 .15 .06 
Exposure 1 .73 .04  
Condition*time point 2 .97 .05  
Condition* Exposure 1 .16 .01  
Time point* Exposure 2 .50 .03  
Condition*time point* Exposure 2 .86 .05  
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Table 5. Mean peak values (SD) during the 5th minute of inhalation for respiratory 
measures in response to the 1st, 2nd and 3rd inhalation tasks during the experimental (i.e., 
yoga) and control (i.e., stretching) sessions. RR=Respiratory Rate, VE=Ventilation, 
Vt=Tidal volume. All values are the peak values reached during the 5th  
minute of the CO2-inhalation task. 
 
Time point RR Vt (liters) VE (liters/min) 
 Yoga Control Yoga Control Yoga Control 
1st inhalation 
task 
29.11 
(6.46) 
28.89 
(4.79) 
1.74 
(.35) 
1.72 
(.33) 
47.26 
(12.81) 
46.21 
(12.12) 
2nd inhalation 
task 
28.61 
(7.73) 
27.50 
(4.74) 
 
    1.76 
    (.33) 
    1.76 
    (.32) 
47.08 
(13.55) 
45.76 
(12.49) 
3rd inhalation 
task 
28.72 
(7.66) 
28.28 
(5.80) 
1.77 
(.32) 
1.74 
(.30) 
47.74 
(14.07) 
47.15 
(12.54) 
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Table 6. ANOVA results for respiratory rate (RR), tidal volume (Vt), ventilation (VE), and 
carbon dioxide production (VCO2). Condition (yoga, control), assessment time point 
(Baseline, immediately post-condition, 1 hour post-condition), minute of exposure (30-
second intervals averaged over the course of the entire 5-minute inhalation task).   
RR df F ηp² p 
Condition 1 .46 .03  
Time point 2 2.56 .15  
Exposure  9 59.67 .80 <.001 
Condition*time point 2 .50 .03  
Condition* Exposure 9 .88 .05  
Time point* Exposure 18 1.12 .07  
Condition*time point* Exposure 18 .60 .04  
Vt df F ηp² p 
Condition 1 1.11 .07  
Time point 2 1.57 .10  
Exposure 9 164.2 .92 <.001 
Condition*time point 2 .03 .00  
Condition* Exposure 9 .94 .06  
Time point*Exposure 18 1.00 .06  
Condition*time point* Exposure 18 1.36 .08  
VE  df  F ηp² p 
Condition 1 1.38 .08  
Time point 2 1.13 .07  
Exposure 9 123.2 .89 <.001 
Condition*time point 2 1.34 .08  
Condition* Exposure 9 .51 .03  
Time point* Exposure 18 1.49 .09  
Condition*time point*Exposure 18 1.44 .09  
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(Table 6 cont.) 
VCO2  df  F ηp² p 
Condition 1 1.71 .10  
Time point 2 .43 .03  
Exposure 9 142.7 .91 <.001 
Condition*time point 2 1.19 .07  
Condition* Exposure 9 .69 .04  
Time point* Exposure 18 1.15 .07  
Condition*time point* Exposure 18 1.32 .08  
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Table 7. ANOVA results for peak respiratory rate (RR), tidal volume (Vt), and ventilation 
(VE) during the last minute of the inhalation task. Condition (yoga, control), Time point 
(Baseline, immediately post yoga/control, 1 hour post yoga/control). None of the F values 
were statistically significant (i.e., p>.05 for all values). 
RR df F ηp² 
Condition 1 .56 .03 
Time point 2 1.24 .07 
Condition*time point 2 .56 .03 
Vt df F ηp² 
Condition 1 .20 .01 
Time point 2 1.61 .09 
Condition*time point 2 .19 .01 
VE  df  F ηp² 
Condition 1 .61 .04 
Time point 2 .70 .04 
Condition*time point 2 .15 .10 
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Table 8. ANOVA results for minute-by-minute VAS-A rating during the 5-minute 
inhalation task. Condition (yoga, control), Time point (Baseline, immediately post 
yoga/control, 1 hour post yoga/control), Minute of exposure (minutes 1 through 5).  
During inhalation VAS-A  df  F ηp² p 
Condition 1 .36 .02  
Time point 2 10.31 .41 <.001 
Minute of exposure 4 30.15 .67 <.001 
Condition*time point 2 4.06 .21 <.05 
Condition* Exposure 4 .87 .06  
Time point* Exposure 8 .30 .02  
Condition* Time point* Exposure 8 .65 .04  
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Figure 1. Timeline of study events. 
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Figure 2. Mean API scores (represented on the y-axis) from pre- to post-exposure collapsed 
over condition and assessment time point. N=18. Error bars represent standard error (SE). 
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Figure 3. Mean SAI scores collapsed over condition and time point from pre- to post-
exposure. N=18. Error bars represent standard error (SE). 
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Figure 4. Mean SAI scores across the 3 assessment time points (i.e., T1, T2, T3) collapsed 
over condition and exposure. N=18. Error bars represent standard error (SE). 
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Figure 5. Mean VAS-A scores from pre- to post-exposure across the 3 assessment time 
points collapsed over condition. N=18. Error bars represent standard error (SE). 
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Figure 6. Mean minute-by-minute VAS-A ratings during each of the 5-minute CO2-
inhalation protocols. T1= pre-condition, T2=immediately post-condition, T3=1 hour post-
condition. Error bars represent standard deviations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-­‐20	  
-­‐10	  
0	  
10	  
20	  
30	  
40	  
50	  
60	  
70	  
80	  
1	   2	   3	   4	   5	   1	   2	   3	   4	   5	   1	   2	   3	   4	   5	  
Yoga	  
Control	  
	  	  	  	  	  	  	  	  	  	  	  	  T1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  T2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  T3	  	  	  
100	  
	  
REFERENCES 
Allan, N. P., Raines, A. M., Capron, D. W., Norr, A. M., Zvolensky, M. J., & Schmidt, N. B. 
 (2014). Identification of anxiety sensitivity classes and clinical cut-scores in a sample of 
 adult smokers: results from a factor mixture model. Journal of Anxiety Disorders, 28(7), 
 696-703. 
Allgulander, C. (2009). Generalized anxiety disorder: between now and DSM-V. Psychiatric 
 Clinics of North America, 32(3), 611-628. 
Argyropoulos, S.V., Bailey, J.E., Hood, S.D., Kendrick, A.H., Rich, A.S., Laszlo, G. et al. 
 (2002). Inhalation of 35% CO2 results in activation of the HPA axis in healthy 
 volunteers. Psychoneuroendocrinology, 27, 715–729.  
Baer, R.A., Smith, G.T., Hopkins, J., Krietemeyer, J., & Toney, L. (2006). Using self-report  
assessment methods to explore facets of mindfulness. Assessment, 13(1), 27–45. 
Bailey, J.E., Argyropoulos, S.V., Lightman, S.L., & Nutt, D.J. (2003). Does the brain 
 noradrenaline  network mediate the effects of the CO2 challenge? Journal of 
 Psychopharmacology, 17, 252–259. 
Bailey, J.E., Argyropoulos, S.V., Kendrick, A.H., & Nutt, D.J. (2005) Behavioural and 
 cardiovascular effects of 7.5% CO2 in human volunteers. Depression and  
 Anxiety, 21, 18–25. 
Bailey, J.E., Kendrick, A., Diaper, A., Potokar, J.P., & Nutt, D.J. (2007). A validation of the 
 7.5% CO2 model of GAD using paroxetine and lorazepam in healthy volunteers. Journal 
 of Psychopharmacology, 21, 42–49. 
101	  
	  
Bailey, J.E., & Nutt, D.J. (2008). GABA-A receptors and the response to CO2inhalation—a 
 translational trans-species model of anxiety? Pharmacology, Biochemistry and 
 Behavior, 90, 51–57.  
Ballenger, J.C., Davidson, J.R.T., Lecrubier, Y., Nutt, D.J., Borkovec, T.D., Rickels, K., Stein, 
 D.J., & Wittchen, H-U. (2001). Consensus statement on generalized anxiety disorder 
 from the International Consensus Group on Depression and Anxiety. Journal of Clinical 
 Psychiatry, 62, 53–58. 
Barlow, D.H., Gorman, J.M., Shear, M.K., & Woods, S.W. (2000). Cognitive–behavioral 
 therapy, imipramine, or their combination for panic disorder: a randomized controlled 
 trial. JAMA, 283(19), 2529–2536. 
Barnes, L. L. B., Harp, D., & Jung, W. S. (2002). Reliability generalization of scores on the 
 Spielberger State–Trait Anxiety Inventory. Educational and Psychological Measurement, 
 62, 603– 618. 
Behar, E., DiMarco, I. D., Hekler, E. B., Mohlman, J., & Staples, A. M. (2009). Current 
 theoretical models of generalized anxiety disorder (GAD): conceptual review and 
 treatment implications. Journal of Anxiety Disorders, 23(8), 1011-1023. 
Bocola, V., Trecco, M. D., Fabbrini, G., Paladini, C., Sollecito, A., & Martucci, N. (1998). 
 Antipanic effect of fluoxetine measured by CO2 challenge test. Biological 
 Psychiatry, 43(8), 612-615. 
Broman-Fulks, J.J., Berman, M.E., Rabian, B.A., & Webster, M.J. (2004). Effects of aerobic 
 exercise on anxiety sensitivity. Behavior Research and Therapy, 42, 125-136. 
102	  
	  
Broocks, A., Bandelow, B., Pekrun, G., George, A., Meyer, T., Bartmann, U., ... & Rüther, E. 
 (1998). Comparison of aerobic exercise, clomipramine, and placebo in the treatment of 
 panic disorder. American Journal of Psychiatry, 155(5), 603-609.  
Brown, K.W. & Ryan, R.M. (2003). The benefits of being present: mindfulness and its role in 
 psychological well-being. Journal of Personality and Social Psychology, 84, 822-848.  
Carlson, L.E. & Brown, K.W. (2005). Validation of the Mindful Attention Awareness Scale in a 
 cancer population. Journal of Psychosomatic Research, 58, 29-33. 
Cassidy, J., Lichtenstein-Phelps, J., Sibrava, N. J., Thomas, C. L., & Borkovec, T. D. (2009). 
 Generalized anxiety disorder: connections with self-reported attachment. Behavior 
 Therapy, 40, 23–38. 
Chapman, J. J., Fraser, S. J., Brown, W. J., & Burton, N. W. (2015). Physical activity and 
 sedentary behaviour of adults with mental illness. Journal of Science and Medicine in 
 Sport, 19(7), 579-584. 
Christopher, M.S., & Gilbert, B.D. (2010). Incremental validity of components of mindfulness in 
 the prediction of satisfaction with life and depression. Current Psychology, 29 (1),10–23. 
Coeytaux, R. R., McDuffie, J., Goode, A., Cassel, S., Porter, W. D., Sharma, P., ... & Williams, 
 J. W. (2014). Evidence map of yoga for high-impact conditions affecting veterans. 
 US Department of Veterans Affairs, Washington, DC. 
Cowen, V.S., & Adams, T.B. (2007) Heart rate in yoga asana practice: a comparison of styles. 
 Journal of Bodywork & Movement Therapies, 11(1),91-95. 
Cowley, D. S., Dager, S. R., McClellan, J., Roy-Byrne, P. P., & Dunner, D. L. (1988). Response 
 to lactate infusion in generalized anxiety disorder. Biological Psychiatry, 24(4), 409-414. 
103	  
	  
de Wit, L., van Straten, A., Lamers, F., Cuijpers, P., & Penninx, B. (2011). Are sedentary 
 television watching and computer use behaviors associated with anxiety and depressive 
 disorders? Psychiatry research, 186(2), 239-243. 
Dannlowski, U., Ohrmann, P., Bauer, J., Kugel, H., Baune, B. T., Hohoff, C., ... & Suslow, T. 
 (2007). Serotonergic genes modulate amygdala activity in major depression. Genes, 
 Brain and Behavior, 6(7), 672-676.  
Deacon, B., & Abramowitz. J. (2006). Anxiety sensitivity and its dimensions across the anxiety 
 disorders. Journal of Anxiety Disorders, 20, 837–857.  
DeBoer, L. B., Powers, M. B., Utschig, A. C., Otto, M. W., & Smits, J. A. (2012). Exploring 
 exercise as an avenue for the treatment of anxiety disorders. Expert Review of 
 Neurotherapeutics, 12(8), 1011-1022. 
Donnell, C.D., & McNally, R.J. (1990). Anxiety sensitivity and panic attacks in a nonclinical 
 population. Behavior Research Theory, (28)1, 83-85.  
Ensari, I., Greenlee, T. A., Motl, R. W., & Petruzzello, S. J. (2015). Meta-analysis of acute 
 exercise effects on state anxiety: an update of randomized controlled trials over the past 
 25 years. Depression and Anxiety, 32(8), 624-634. 
Esquivel, G., Schruers, K., Kuipers, H., & Griez, E. (2002). The effects of acute exercise and 
 high lactate levels on 35% CO2 challenge in healthy volunteers. Acta Psychiatrica 
 Scandinavica, 106(5), 394-397. 
Esquivel, G., Díaz-Galvis, J., Schruers, K., Berlanga, C., Lara-Muñoz, C., & Griez, E. (2008). 
 Acute exercise reduces the effects of a 35% CO2 challenge in patients with panic 
 disorder. Journal of Affective Disorders, 107(1), 217-220. 
104	  
	  
Esquivel, G., Dandachi, A., Knuts, I., Goossens, L., Griez, E., & Schruers, K. (2012). Effects of 
 acute exercise on CO2‐induced fear. Depression and Anxiety, 29(2), 156-159. 
Fava, M., & Rosenbaum, J. F. (1998). Anger attacks in depression. Depression and 
 Anxiety, 8(S1), 59-63. 
Field, A. (2013). Discovering statistics using IBM SPSS Statistics. Fourth Edition. London: Sage. 
Foa, E. B., Liebowitz, M. R., Kozak, M. J., Davies, S., Campeas, R., Franklin, M. E., ... & 
 Simpson, H. B. (2005). Randomized, placebo-controlled trial of exposure and ritual 
 prevention, clomipramine, and their combination in the treatment of obsessive-
 compulsive disorder. American Journal of Psychiatry, 162(1), 151-161.  
Fremont, J., & Craighead, L.W. (1987). Aerobic exercise and cognitive therapy in the treatment 
 of dysphoric moods. Cognitive Therapy and Research, 11, 241–251.  
Glover, E. M., Jovanovic, T., & Norrholm, S. D. (2015). Estrogen and extinction of fear  
memories: implications for posttraumatic stress disorder treatment. Biological 
Psychiatry, 78(3), 178-185. 
Gould, R. A., Ball, S., Kaspi, S. P., Otto, M. W., Pollack, M. H., Shekhar, A., & Fava, M. 
 (1996). Prevalence and correlates of anger attacks: a two site study. Journal of Affective 
 Disorders, 39(1), 31-38. 
Gould, R.A., Otto, M.W., Pollack, M.H., & Yap, L. (1997). Cognitive behavioral and 
 pharmacological treatment of generalized anxiety disorder: a preliminary meta-analysis. 
 Behavior Therapy, 28(2), 285-305. 
Hariri, A.R., Mattay, V.S., Tessitore, A., Kolachana, B., Fera, F., Goldman, D., Egan, M.F., 
 & Weinberger, D.R. (2002). Serotonin transporter genetic variation and the response of 
 the human amygdala. Science, 297, 400–403. 
105	  
	  
Helgadottir, B., Forsell, Y., & Ekblom, Ö. (2015). Physical activity patterns of people affected 
 by depressive and anxiety disorders as measured by accelerometers: a cross-sectional 
 study. PloS One, 10(1). 
Herring, M. P., Lindheimer, J. B., & O’Connor, P. J. (2013). The effects of exercise training on 
 anxiety. American Journal of Lifestyle Medicine, 8(6), 388-403. 
Herring, M. P., O’Connor, P. J., & Dishman, R. K. (2010). The effect of exercise training on 
 anxiety symptoms among patients: a systematic review. Archives of Internal Medicine, 
 170(4), 321-331. 
Hettema, J. M., Neale, M. C., & Kendler, K. S. (2001). A review and meta-analysis of the 
 genetic epidemiology of anxiety disorders. American Journal of Psychiatry, 
 158(10), 1568-1578. 
Hishinuma, E. S., Miyamoto, R. H., Nishimura, S. T., Nahulu, L. B., Andrade, N. N., Makini, G. 
 K., ... & Guerrero, A. P. (2000). Psychometric properties of the state-trait anxiety 
 inventory for Asian/Pacific-islander adolescents. Assessment, 7(1), 17-36.  
Hofmann, S. G., & Smits, J. A. (2008). Cognitive-behavioral therapy for adult anxiety disorders: 
 a meta-analysis of randomized placebo-controlled trials. The Journal of Clinical 
 Psychiatry, 69(4), 621-632. 
Iyengar, B. K. S. (1979). Light on Yoga. New York: Schocken Books. 
Jayakody K., Gunadasa S., & Hosker C. (2014). Exercise for anxiety disorders: systematic 
 review. British Journal of Sports and Medicine, 48, 187–196.  
 doi: 10.1136/bjsports-2012-091287 
Kabacoff, R. I., Segal, D. L., Hersen, M., & Van Hasselt, V. B. (1997). Psychometric properties 
 and diagnostic utility of the Beck Anxiety Inventory and the State–Trait Anxiety 
106	  
	  
 Inventory with older adult psychiatric outpatients. Journal of Anxiety Disorders, 11, 33– 
 47. 
Kemper, C. J., Lutz, J., Bähr, T., Rüddel, H., & Hock, M. (2012). Construct validity of the 
 anxiety sensitivity index–3 in clinical samples. Assessment, 19(1), 89-100. 
Kessler, R.C., Berglund, P.A., Demler, O., Jin, R., & Walters, E.E. (2005). Lifetime prevalence 
 and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey 
 Replication (NCS R). Archives of General Psychiatry, 62, 593–602. 
Kessler, R.C., Chiu, W.T., Demler, O., Merikangas, K.R., & Walters, E.E. (2005a). Prevalence, 
 severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity 
 Survey Replication. Archives of General Psychiatry, 62, 617–627. 
Kessler, R.C., Keller, M.B., & Wittchen, H-U. (2001b). The epidemiology of generalized anxiety 
 disorder. Psychiatry Clinics of North America, 24, 19–39. 
Killien, M., Bigby, J. A., Champion, V., Fernandez-Repollet, E., Jackson, R. D., Kagawa-Singer,  
M., ... & Prout, M. (2000). Involving minority and underrepresented women in clinical 
trials: the National Centers of Excellence in Women's Health. Journal of Women's Health 
& Gender-based Medicine, 9(10), 1061-1070. 
Kim, A. M., Tingen, C. M., & Woodruff, T. K. (2010). Sex bias in trials and treatment must  
end. Nature, 465(7299), 688-689. 
Kinser, P.A., & Robbins, J.L. (2013). Control Group Design: enhancing Rigor in Research of  
Mind-Body Therapies for Depression. Evidence-Based Complementary and Alternative 
Medicine, Article ID 140467, 10 pages. http://dx.doi.org/10.1155/2013/140467 
107	  
	  
Klaassen, T., Klumperbeek, J., Deutz, N.E., van Praag, H.M., & Griez, E. (1998). Effects of 
 tryptophan depletion on anxiety and on panic provoked by carbon dioxide challenge. 
 Psychiatry Research, 77, 167–74. 
Klein, D.F. (1980). Anxiety reconceptualized. Comprehensive Psychiatry, 21, 411-427. 
Kroenke, K., Spitzer, R.L., Williams, J.B.W., Monahan, P.O., & Löwe, B. (2007). Anxiety 
 disorders in primary care: prevalence, impairment, comorbidity, and detection. Annals of 
 Internal Medicine, 146, 317-325.   
Liebowitz, M.R., Fyer A.J., Gorman J.M., Dillon, D., Appleby, I. L., Levy, G., ... & Klein, D. F. 
 (1984). “Lactate provocation of Panic Attacks. I. Clinical and Behavioral Findings”. 
 Archives of General Psychiatry, 41(8), 764-770. 
Ludman, E., Katon, W., Russo, J., Simon, G., Von Korff, M., Lin, E., ... & Kinder, L. (2006). 
 Panic episodes among patients with diabetes. General Hospital Psychiatry, 28(6), 475-
 481.  
McEntee, D.J., & Halgin, R.P. (1996). Therapists' attitudes about addressing the role of exercise 
 in psychotherapy. Journal of Clinical Psychology, 52(1), 48-60. 
McLean, C.P., Asnaani, A., Litz, B.T., & Hofmann, S.G. (2011). Gender differences in anxiety 
 disorders: prevalence, course of illness, comorbidity and burden of illness. Journal of 
 Psychiatric Research, 45(8), 1027-1035. 
Mitte,  K. (2005). Meta-analysis of cognitive-behavioral treatments for generalized anxiety 
 disorder. Psychology Bulletin, 131 (5), 785-795 
Moffitt, T.E., Caspi, A., Harrington, H., Milne, B.J., Melchior, M., Goldberg, D., & Poulton, R. 
 (2007). Generalized anxiety disorder and depression: childhood risk factors in a birth 
 cohort followed to age 32. Psychological Medicine, 37(03), 441-452. 
108	  
	  
Mohr, D.C., Ho, J., Duffecy, J., Baron, K.G., Lehman, K.A., Jin, L., & Reifler, D. (2010). 
 Perceived barriers to psychological treatments and their relationship to depression. 
 Journal of Clinical Psychology, 66, 394–409. 
Moscovitch, D.A., McCabe, R.E., Antony, M.M., Rocca, L., & Swinson, R.P. (2008). Anger  
experience and expression across the anxiety disorders. Depression and Anxiety, 25(2),  
107-113. 
National Institute of Mental Health. (2001). Mental disorders in America [online]. 
 www.nimh.nih.gov. Accessed June 6th, 2015. 
National Center for Complementary and Alternative Medicine. (2015).Yoga for Health. 
 Accessed August 3rd, 2015. http://nccam.nih.gov/health/yoga/introduction.htm#use. 
Nillni, Y. I., Rohan, K. J., & Zvolensky, M. J. (2012). The role of menstrual cycle phase and 
 anxiety sensitivity in catastrophic misinterpretation of physical symptoms during a CO2 
 challenge. Archives of Women's Mental Health, 15(6), 413-422. 
Vesga-López, O., Schneier, F., Wang, S., Heimberg, R., Liu, S. M., Hasin, D. S., & Blanco, C. 
 (2008). Gender differences in generalized anxiety disorder: results from the National 
 Epidemiologic Survey on Alcohol and Related Conditions (NESARC). The Journal of 
 Clinical Psychiatry, 69(10), 1606-1616. 
Oken, B. S., Kishiyama, S., Zajdel, D., Bourdette, D., Carlsen, J., Haas, M., ... & Mass, M. 
 (2004). Randomized controlled trial of yoga and exercise in multiple sclerosis. 
 Neurology, 62(11), 2058-2064.  
Oken, B. S., Zajdel, D., Kishiyama, S., Flegal, K., Dehen, C., Haas, M., ... & Leyva, J. (2006). 
 Randomized, controlled, six-month trial of yoga in healthy seniors: effects on cognition 
 and quality of life. Alternative Therapies in Health and Medicine, 12(1), 40-47.  
109	  
	  
Olatunji, B. O., Cisler, J. M., & Tolin, D. F. (2007). Quality of life in the anxiety disorders: a 
 meta-analytic review. Clinical Psychology Review, 27(5), 572-581. 
Olthuis, J. V., Watt, M. C., & Stewart, S. H. (2014). Anxiety Sensitivity Index (ASI-3) subscales 
 predict unique variance in anxiety and depressive symptoms. Journal of Anxiety 
 Disorders, 28(2), 115-124. 
Ormel, J., Van Den Brink, W., Koeter, M. W., Giel, R., Van Der Meer, K., Van De Willige, G., 
 & Wilmink, F.W. (1990). Recognition, management and outcome of psychological 
 disorders in primary care: a naturalistic follow-up study. Psychological Medicine, 20, 
 909–923. 
Papp, L. A., Martinez, J. M., Klein, D. F., Coplan, J. D., Norman, R. G., Cole, R., ... & Gorman, 
 J. M. (1997). Respiratory psychophysiology of panic disorder: three respiratory 
 challenges in 98 subjects. American Journal of Psychiatry, 154(11), 1557-1565. 
Papadopoulos, A., Rich, A., Nutt, D., & Bailey, J. (2008). The effects of single dose anxiolytic 
 medication on the CO2 models of anxiety: differentiation of subjective and objective 
 measures. Journal of Psychopharmacology, doi:10.1177/0269881108097716. 
Pigott, T.A. (2003). Anxiety disorders in women. Psychiatric Clinics of North America, 26, 621-
 672, vi-vii. 
Perna, G., Brambilla, F., Aranio, C., & Bellodi, L. (1995). Menstrual cycle-related sensitivity to 
 35% CO2 in panic patients. Biological Psychiatry, 37(8), 528–532. 
Plehn, K., Peterson, R. A., & Williams, D. A. (1998). Anxiety sensitivity: its relationship to 
 functional status in patients with chronic pain. Journal of Occupational 
 Rehabilitation, 8(3), 213-222. 
110	  
	  
Peterson, R. A., & Plehn, K. (1999). Measuring anxiety sensitivity. In S. Taylor (Ed.), Anxiety 
 sensitivity: theory, research and the treatment of the fear of anxiety (pp. 61–81). 
 Mahwah, NJ: Erlbaum. 
Peterson, R.A., & Reiss, S. (1992). In R.A Peterson and S Reiss. Anxiety Sensitivity Index 
 Revised Manual. Worthington, OH: International Diagnostic Systems Publishing 
 Corporation. 
Petruzzello, S. J., Landers, D. M., Hatfield, B. D., Kubitz, K. A., & Salazar, W. (1991). A meta-
 analysis on the anxiety-reducing effects of acute and chronic exercise. Sports 
 Medicine, 11(3), 143-182. 
Poma, S. Z., Milleri, S., Squassante, L., Nucci, G., Bani, M., Perini, G. I., & Merlo-Pich, E. 
 (2005). Characterization of a 7% carbon dioxide (CO2) inhalation paradigm to evoke 
 anxiety symptoms in healthy subjects. Journal of Psychopharmacology, 19(5), 494-503. 
Rapee, R., Brown, T., Antony, M., & Barlow, D. (1992). Response to hyperventilation and 
 inhalation of 5.5% carbon dioxide-enriched air across the DSM-III-R anxiety disorders. 
 Journal of Abnormal Psychology, 101, 538–552. 
Ramos A., Kangerski A.L., Basso P.F., Da Silva Santos, J.E., Assreuy, J., Vendruscolo, L.F., 
 & Takahashi R.N. (2002). Evaluation of Lewis and SHR rat strains as a genetic model for 
 the study of anxiety and pain. Behavioral Brain Research, 129, 113-123. 
Rector, N.A., Szacun-Shimizu, K., & Leybman, M. (2007). Anxiety sensitivity within the 
 anxiety disorders: disorder-specific sensitivities and depression comorbidity. Behaviour 
 Research and Therapy, 45, 1967–1975.  
Reiss, R., Peterson, R.A., Gursky, D.M., & McNally, R.J. (1986). Anxiety sensitivity, anxiety 
 frequency, and the prediction of fearfulness. Behaviour Research and Therapy, 24,1–8. 
111	  
	  
Rieker, P. P., & Bird, C. E. (2005). Rethinking gender differences in health: why we need to 
 integrate social and biological perspectives. The Journals of Gerontology Series B: 
 Psychological Sciences and Social Sciences, 60(2), S40-S47.  
Roy, M-A., Neale, M.C., Pedersen, N.L., Mathe, A.A., & Kendler, K.S. (1995). A twin study of 
 generalized anxiety disorder and major depression. Psychological Medicine, 25, 1037–
 1049. 
Sandroff, B. M., Hillman, C. H., Benedict, R. H., & Motl, R. W. (2015). Acute effects of  
walking, cycling, and yoga exercise on cognition in persons with relapsing-remitting 
multiple sclerosis without impaired cognitive processing speed. Journal of Clinical and 
Experimental Neuropsychology, 37(2), 209-219. 
Sareen, J., Cox, B.J., Clara, I., & Asmundson, G.J.G. (2005).The relationship between anxiety 
 disorders and physical disorders in the U.S. National Comorbidity Survey. Depression 
 and Anxiety, 21, 193-202. 
Saunders E.F., Fitzgerald K.D., Zhang P., & McInnis M.G. (2012).Clinical features of bipolar 
 disorder comorbid with anxiety disorders differ between men and women. Depression 
 and Anxiety, 29(8), 739-46. 
Schaefer, K. E. (1958). Respiratory pattern and respiratory response to CO2. Journal of Applied 
 Physiology, 13(1), 1-14. 
Seddon, K., Morris, K., Bailey, J., Potokar, J., Rich, A., Wilson, S., Bettica, P., et al. (2011). 
 Effects of 7.5% CO2 challenge in generalized anxiety disorder. Journal of  
 Psychopharmacology, 25, 43-51. 
Shearer, S. L. (2007). Recent advances in the understanding and treatment of anxiety 
 disorders. Primary Care: Clinics in Office Practice, 34(3), 475-504. 
112	  
	  
Sherman, K. J. (2012). Guidelines for developing yoga interventions for randomized 
 trials. Evidence-Based Complementary and Alternative Medicine, Article ID 143271, 16 
 pages. doi:10.1155/2012/143271 
Siegling, A. B., & Petrides, K. V. (2013). Measures of trait mindfulness: convergent validity, 
 shared dimensionality, and linkages to the five-factor model. Frontiers in Psychology, 5, 
 1164-1164. 
Sinha, S.S., Coplan, J.D., Pine, D.S., Martinez, J.A., Klein, D.F., & Gorman, J.M. (1999) Panic 
 induced by carbon dioxide inhalation and lack of hypothalamic-pituitary-adrenal axis 
 activation. Psychiatry Research, 86, 93–98. 
Smits, J. A., Meuret, A. E., Zvolensky, M. J., Rosenfield, D., & Seidel, A. (2009). The effects of 
 acute exercise on CO2 challenge reactivity. Journal of Psychiatric Research, 43(4), 446-
 454. 
Spielberger, C.D., Gorsuch, R.L., Lushene, R.E., Vagg, P.R., & Jacobs, G. A. (1983). 
 Manual for the State-Trait Anxiety Inventory STAI (Form Y). Palo Alto, CA: Consulting 
 Psychologists Press. 
Spielberger, C.D. (1988). State-Trait Anger Expression Inventory (STAXI). Research edition. 
 Odessa, FL: Psychological Assessment Resources. 
Spitzer, R. L., Kroenke, K., Williams, J. B., & Löwe, B. (2006). A brief measure for assessing 
 generalized anxiety disorder: the GAD-7. Archives of Internal Medicine,166 (10),1092-
 1097. 
Stephens, M. (2012). Yoga Sequencing: designing transformative yoga classes. Berkeley, CA: 
 North Atlantic Books. 
113	  
	  
Taylor, S., Zvolensky, M. J., Cox, B. J., Deacon, B., Heimberg, R. G., Ledley, D. R., ... & Coles, 
 M. (2007). Robust dimensions of anxiety sensitivity: development and initial validation 
 of the Anxiety Sensitivity Index-3. Psychological Assessment, 19(2), 176. 
Torgersen, S. (1983). Genetic factors in anxiety disorders. Archives of General 
 Psychiatry, 40(10), 1085-1089. 
The Department of Health and Human Services (USDHHS). (2008). Physical Activity 
 Guidelines Advisory Committee final report. 
 www.health.gov/PAGuidelines/Report/Default.aspx. Accessed: June 9th, 2016. 
Vautier, S. (2004). A longitudinal SEM approach to STAI data: two comprehensive multitrait–
 multistate models. Journal of Personality Assessment, 83,167–179 
Vesga-López, O., Schneier, F. R., Wang, S., Heimberg, R. G., Liu, S. M., Hasin, D. S., & 
 Blanco, C. (2008). Gender differences in generalized anxiety disorder: results from the 
 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). The 
 Journal of Clinical Psychiatry, 69(10), 1-478. 
Viana, A.G., & Rabian, B. (2008). Perceived attachment: relations to anxiety sensitivity, worry, 
 and GAD symptoms. Behaviour Research and Therapy, 46, 737–747.  
Wang, P. S., Demler, O., & Kessler, R. C. (2002). Adequacy of treatment for serious mental 
 illness in the United States. American Journal of Public Health, 92(1), 92-98. 
Wang, P.S., Lane, M., Olfson, M., Pincus, H.A., Wells, K.B., & Kessler, R.C. (2005). Twelve-
 month use of mental health services in the United States: results from the national 
 comorbidity survey replication. Archives of General Psychiatry, 62, 629–640. 
114	  
	  
Williams, V. S., Morlock, R. J., & Feltner, D. (2010). Psychometric evaluation of a visual analog 
 scale for the assessment of anxiety. Health and Quality of Life Outcomes, 8:57.  
Whiting, P. J. (2006). GABA-A receptors: a viable target for novel anxiolytics? Current 
 Opinion in Pharmacology, 6(1), 24-29. 
Wittchen, H.U., Carter, R.M., Pfister, H., Montgomery. S.A., & Kessler, R.C. (2000). 
 Disabilities and quality of life in pure and comorbid generalized anxiety disorder and 
 major depression in a national survey. International Clinical Psychopharmacology, 15, 
 319–328. 
Woods, S.W., Charney, D.S., Lake, J., Goodman, W.K., Redmond, D.E., & Heninger, G.R. 
 (1986).Carbon dioxide sensitivity in panic anxiety.  Archives of General Psychiatry, 43, 
 900–909. 
Woods, S.W., Krystal, J.H., Heninger, G.R., & Charney, D.S. (1989). Effects of alprazolam and 
 clonidine on carbon dioxide-induced increases in anxiety ratings in healthy human 
 subjects.  Life Science, 45, 233–242. 
Yurkuran M, Alp A, Yurtkuran M, & Dilek K. (2007). A modified yoga-based exercise program 
 in hemodialysis patients: a randomized controlled study. Complementary Therapies in 
 Medicine, 15, 164–171. 
Zandbergen, J., Pols, H., de Loof, C., & Griez, E.J. (1991). Ventilatory response to CO2 in  
panic disorder. Psychiatry Research, 39(1), 13-19. 
Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta 
 Psychiatrica Scandinavica, 67(6), 361-370. 
 
